Jean Sibilia
#134,576
Most Influential Person Now
Researcher
Jean Sibilia's AcademicInfluence.com Rankings
Jean Sibiliabiology Degrees
Biology
#9107
World Rank
#12272
Historical Rank
Cell Biology
#382
World Rank
#392
Historical Rank
Immunology
#540
World Rank
#557
Historical Rank
Molecular Biology
#1214
World Rank
#1240
Historical Rank
Download Badge
Biology
Jean Sibilia's Degrees
- PhD Biomedical Sciences University of Strasbourg
- Masters Biochemistry Université Paris Cité
Why Is Jean Sibilia Influential?
(Suggest an Edit or Addition)Jean Sibilia's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Early detection of pulmonary arterial hypertension in systemic sclerosis: a French nationwide prospective multicenter study. (2005) (738)
- Activation of IFN pathways and plasmacytoid dendritic cell recruitment in target organs of primary Sjögren's syndrome. (2006) (565)
- Anticitrullinated protein/peptide antibody assays in early rheumatoid arthritis for predicting five year radiographic damage (2003) (480)
- Treatment of rheumatoid arthritis with the selective costimulation modulator abatacept: twelve-month results of a phase iib, double-blind, randomized, placebo-controlled trial. (2005) (461)
- Inefficacy of infliximab in primary Sjögren's syndrome: results of the randomized, controlled Trial of Remicade in Primary Sjögren's Syndrome (TRIPSS). (2004) (437)
- Tolerance and short term efficacy of rituximab in 43 patients with systemic autoimmune diseases (2004) (419)
- Incidence and prevalence of systemic sclerosis: a systematic literature review. (2008) (419)
- Interleukin-1 receptor antagonist (anakinra) treatment in patients with systemic-onset juvenile idiopathic arthritis or adult onset Still disease: preliminary experience in France (2007) (417)
- Lymphomas in rheumatoid arthritis patients treated with methotrexate: a 3-year prospective study in France. (2002) (416)
- Women, men, and rheumatoid arthritis: analyses of disease activity, disease characteristics, and treatments in the QUEST-RA Study (2009) (402)
- Systemic lupus erythematosus induced by anti-tumour necrosis factor alpha therapy: a French national survey (2005) (389)
- Safety and efficacy of rituximab in systemic lupus erythematosus: results from 136 patients from the French AutoImmunity and Rituximab registry. (2010) (379)
- Efficacy of etanercept for the treatment of juvenile idiopathic arthritis according to the onset type. (2003) (364)
- Outcomes of a multicentre randomised clinical trial of etanercept to treat ankylosing spondylitis (2004) (309)
- Bone mineral density in men treated with synthetic gonadotropin-releasing hormone agonists for prostatic carcinoma. (1999) (305)
- Tolerance and efficacy of rituximab and changes in serum B cell biomarkers in patients with systemic complications of primary Sjögren’s syndrome (2006) (302)
- Prognostic factors for radiographic damage in early rheumatoid arthritis: a multiparameter prospective study. (2001) (301)
- Prevalence of Pulmonary Hypertension in Systemic Sclerosis in European Caucasians and Metaanalysis of 5 Studies (2010) (267)
- Risk factors for severe infections in patients with rheumatoid arthritis treated with rituximab in the autoimmunity and rituximab registry. (2010) (261)
- Work disability remains a major problem in rheumatoid arthritis in the 2000s: data from 32 countries in the QUEST-RA Study (2010) (248)
- Anti-HMGCR Autoantibodies in European Patients With Autoimmune Necrotizing Myopathies (2014) (243)
- Lymphomas in Patients With Sjögren's Syndrome Are Marginal Zone B-Cell Neoplasms, Arise in Diverse Extranodal and Nodal Sites, and Are Not Associated With Viruses (1997) (241)
- MUC5B Promoter Variant and Rheumatoid Arthritis with Interstitial Lung Disease (2018) (240)
- Effects of hydroxychloroquine on symptomatic improvement in primary Sjögren syndrome: the JOQUER randomized clinical trial. (2014) (236)
- Hierarchical cluster and survival analyses of antisynthetase syndrome: phenotype and outcome are correlated with anti-tRNA synthetase antibody specificity. (2012) (230)
- Anti-tumor necrosis factor alpha therapy in fifteen patients with AA amyloidosis secondary to inflammatory arthritides: a followup report of tolerability and efficacy. (2003) (228)
- Incidence and prevalence of inflammatory myopathies: a systematic review. (2015) (215)
- Schnitzler's syndrome: diagnosis, treatment, and follow‐up (2013) (210)
- Efficacy of rituximab in systemic manifestations of primary Sjögren's syndrome: results in 78 patients of the AutoImmune and Rituximab registry (2012) (195)
- Comparison of individually tailored versus fixed-schedule rituximab regimen to maintain ANCA-associated vasculitis remission: results of a multicentre, randomised controlled, phase III trial (MAINRITSAN2) (2018) (192)
- Association between the IRF5 rs2004640 functional polymorphism and systemic sclerosis: a new perspective for pulmonary fibrosis. (2009) (192)
- The three-year incidence of pulmonary arterial hypertension associated with systemic sclerosis in a multicenter nationwide longitudinal study in France. (2009) (187)
- Tumour necrosis factor α blocking agents in refractory adult Still’s disease: an observational study of 20 cases (2004) (186)
- Treatment of primary Sjögren syndrome with rituximab: a randomized trial. (2014) (185)
- Treatment of Primary Sjgren Syndrome With Rituximab (2014) (184)
- The ESPOIR cohort: a ten-year follow-up of early arthritis in France: methodology and baseline characteristics of the 813 included patients. (2007) (181)
- Risk factors for death and the 3-year survival of patients with systemic sclerosis: the French ItinérAIR-Sclérodermie study (2008) (179)
- Mevalonate Kinase Deficiency: A Survey of 50 Patients (2011) (179)
- Efficacy of anti-TNF alpha in severe and/or refractory Behçet's disease: Multicenter study of 124 patients. (2015) (170)
- TLR2 Expression Is Regulated by MicroRNA miR-19 in Rheumatoid Fibroblast-like Synoviocytes (2012) (169)
- In primary Sjögren's syndrome, HLA class II is associated exclusively with autoantibody production and spreading of the autoimmune response. (2003) (165)
- Prevalence of anti-cyclic citrullinated peptide and anti-keratin antibodies in patients with primary Sjögren’s syndrome (2004) (159)
- STAT4 is a genetic risk factor for systemic sclerosis having additive effects with IRF5 on disease susceptibility and related pulmonary fibrosis. (2009) (156)
- Evaluation of cardiac abnormalities by Doppler echocardiography in a large nationwide multicentric cohort of patients with systemic sclerosis (2007) (153)
- Non-TNF-Targeted Biologic vs a Second Anti-TNF Drug to Treat Rheumatoid Arthritis in Patients With Insufficient Response to a First Anti-TNF Drug: A Randomized Clinical Trial. (2016) (152)
- Serum Levels of Beta2-Microglobulin and Free Light Chains of Immunoglobulins Are Associated with Systemic Disease Activity in Primary Sjögren’s Syndrome. Data at Enrollment in the Prospective ASSESS Cohort (2013) (148)
- B cell activation biomarkers as predictive factors for the response to rituximab in rheumatoid arthritis: a six-month, national, multicenter, open-label study. (2011) (147)
- Serum immunoglobulin free light chain assessment in rheumatoid arthritis and primary Sjögren’s syndrome (2006) (143)
- Tocilizumab in refractory adult Still's disease (2011) (140)
- Intrafamilial Exposure to SARS-CoV-2 Associated with Cellular Immune Response without Seroconversion, France (2020) (136)
- The world-wide burden of musculoskeletal diseases: a systematic analysis of the World Health Organization Burden of Diseases Database (2019) (135)
- Systemic sclerosis-associated Sjögren's syndrome and relationship to the limited cutaneous subtype: results of a prospective study of sicca syndrome in 133 consecutive patients. (2006) (135)
- Prognostic factors of 10-year radiographic outcome in early rheumatoid arthritis: a prospective study (2008) (134)
- Prognostic factors for remission in early rheumatoid arthritis: a multiparameter prospective study (2004) (134)
- Methotrexate therapy for rheumatoid arthritis: clinical practice guidelines based on published evidence and expert opinion. (2006) (134)
- Lymphomas in patients with Sjogren's syndrome are marginal zone B-cell neoplasms, arise in diverse extranodal and nodal sites, and are not associated with viruses. (1997) (133)
- Rheumatic disorders developed after hepatitis B vaccination. (1999) (131)
- Management of nontuberculous infectious discitis. treatments used in 110 patients admitted to 12 teaching hospitals in France. (2001) (131)
- Efficacy of infliximab in refractory ankylosing spondylitis: results of a six-month open-label study. (2002) (130)
- Impact of a nurse-led programme on comorbidity management and impact of a patient self-assessment of disease activity on the management of rheumatoid arthritis: results of a prospective, multicentre, randomised, controlled trial (COMEDRA) (2014) (129)
- Predictive factors of 5-year health assessment questionnaire disability in early rheumatoid arthritis. (2003) (128)
- The familial form of spondylarthropathy: a clinical study of 115 multiplex families. Groupe Français d'Etude Génétique des Spondylarthropathies. (2000) (125)
- Positivity for anti-cyclic citrullinated peptide is associated with a better response to abatacept: data from the ‘Orencia and Rheumatoid Arthritis’ registry (2012) (125)
- Autologous bone marrow transplantation in the treatment of refractory systemic sclerosis: early results from a French multicentre phase I–II study (2002) (124)
- Evaluation of anti-citrullinated filaggrin antibodies as hallmarks for the diagnosis of rheumatic diseases (2004) (124)
- Shared genetic predisposition in rheumatoid arthritis-interstitial lung disease and familial pulmonary fibrosis (2017) (123)
- Efficacy of Biological-Targeted Treatments in Takayasu Arteritis: Multicenter, Retrospective Study of 49 Patients. (2015) (121)
- Detection of Borrelia burgdorferi by DNA amplification in synovial tissue samples from patients with Lyme arthritis. (1996) (120)
- Bruton’s Tyrosine Kinase Is Involved in miR-346-Related Regulation of IL-18 Release by Lipopolysaccharide-Activated Rheumatoid Fibroblast-Like Synoviocytes 1 (2009) (120)
- Differentiation of follicular helper T cells by salivary gland epithelial cells in primary Sjögren's syndrome. (2014) (118)
- Evaluation of two strategies (initial methotrexate monotherapy vs its combination with adalimumab) in management of early active rheumatoid arthritis: data from the GUEPARD trial. (2009) (114)
- BANK1 is a genetic risk factor for diffuse cutaneous systemic sclerosis and has additive effects with IRF5 and STAT4. (2009) (113)
- A randomised, multicentre, double-blind, placebo-controlled trial of etanercept in adults with refractory heel enthesitis in spondyloarthritis: the HEEL trial (2010) (112)
- Pulmonary hypertension in antisynthetase syndrome: prevalence, aetiology and survival (2013) (111)
- Intrafamilial Exposure to SARS-CoV-2 Induces Cellular Immune Response without Seroconversion (2020) (111)
- The PTPN22 620W allele confers susceptibility to systemic sclerosis: findings of a large case-control study of European Caucasians and a meta-analysis. (2008) (110)
- In Vivo Expression Pattern of MICA and MICB and Its Relevance to Auto-Immunity and Cancer (2007) (107)
- Remitting seronegative symmetrical synovitis with pitting edema (RS3PE): a form of paraneoplastic polyarthritis? (1999) (107)
- B lymphocytes and B-cell activating factor promote collagen and profibrotic markers expression by dermal fibroblasts in systemic sclerosis (2013) (107)
- MiR-20a regulates ASK1 expression and TLR4-dependent cytokine release in rheumatoid fibroblast-like synoviocytes (2012) (106)
- Pneumomediastinum in interstitial lung disease associated with dermatomyositis and polymyositis. (2008) (105)
- Tumour necrosis factor alpha blocking agents in refractory adult Still's disease: an observational study of 20 cases. (2005) (103)
- Epidemiology of juvenile idiopathic arthritis in Alsace, France. (2006) (102)
- Anakinra in Adult‐Onset Still's Disease: Long‐Term Treatment in Patients Resistant to Conventional Therapy (2013) (101)
- Inhibition of clinical benefits of aspirin on first myocardial infarction by nonsteroidal antiinflammatory drugs. (2004) (99)
- Efficacy and tolerance of infliximab in refractory Takayasu arteritis: French multicentre study. (2012) (98)
- Favorable effect of very early disease-modifying antirheumatic drug treatment on radiographic progression in early inflammatory arthritis: Data from the Étude et Suivi des polyarthrites indifférenciées récentes (study and followup of early undifferentiated polyarthritis). (2011) (96)
- Vaccination recommendations for the adult immunosuppressed patient: A systematic review and comprehensive field synopsis. (2017) (96)
- Direct Molecular Typing of Borrelia burgdorferi Sensu Lato Species in Synovial Samples from Patients with Lyme Arthritis (2000) (95)
- miR-346 Controls Release of TNF-α Protein and Stability of Its mRNA in Rheumatoid Arthritis via Tristetraprolin Stabilization (2011) (94)
- Tocilizumab in patients with active rheumatoid arthritis and inadequate responses to DMARDs and/or TNF inhibitors: a large, open-label study close to clinical practice (2012) (94)
- Cardiovascular risk and rheumatoid arthritis: clinical practice guidelines based on published evidence and expert opinion. (2006) (93)
- Blood memory B cells are disturbed and predict the response to rituximab in patients with rheumatoid arthritis. (2011) (92)
- Serial determination of cyclic citrullinated peptide autoantibodies predicted five-year radiological outcomes in a prospective cohort of patients with early rheumatoid arthritis (2006) (90)
- Percutaneous laser photocoagulation of spinal osteoid osteomas under CT guidance. (1998) (89)
- Clinical spectrum and therapeutic management of systemic lupus erythematosus-associated macrophage activation syndrome: A study of 103 episodes in 89 adult patients. (2017) (88)
- Value of 18F‐FDG‐PET/CT in patients with fever of unknown origin and unexplained prolonged inflammatory syndrome: a single centre analysis experience (2010) (88)
- Disease activity score-driven therapy versus routine care in patients with recent-onset active rheumatoid arthritis: data from the GUEPARD trial and ESPOIR cohort (2011) (86)
- Infliximab or rituximab for refractory Wegener's granulomatosis: long-term follow up. A prospective randomised multicentre study on 17 patients. (2011) (85)
- NLRP1 influences the systemic sclerosis phenotype: a new clue for the contribution of innate immunity in systemic sclerosis-related fibrosing alveolitis pathogenesis (2010) (85)
- Diagnostic value of serum and synovial procalcitonin in acute arthritis: a prospective study of 42 patients. (2005) (84)
- Safety of T-cell co-stimulation modulation with abatacept in patients with rheumatoid arthritis. (2007) (83)
- Fcγ receptor type IIIA polymorphism influences treatment outcomes in patients with rheumatoid arthritis treated with rituximab (2012) (83)
- NF‐κB and the MAP kinases/AP‐1 pathways are both involved in interleukin‐6 and interleukin‐8 expression in fibroblast‐like synoviocytes stimulated by protein I/II, a modulin from oral streptococci (2001) (81)
- Correlation of serum B lymphocyte stimulator and β2 microglobulin with autoantibody secretion and systemic involvement in primary Sjögren’s syndrome (2005) (81)
- Tumor Necrosis Factor-α Blockers in SAPHO Syndrome (2010) (80)
- Severe Health‐Related Quality of Life Impairment in Active Primary Sjögren's Syndrome and Patient‐Reported Outcomes: Data From a Large Therapeutic Trial (2017) (80)
- Skeletal muscle mitochondrial dysfunction during chronic obstructive pulmonary disease: central actor and therapeutic target (2013) (79)
- Rituximab: Recommendations of the French Vasculitis Study Group (FVSG) for induction and maintenance treatments of adult, antineutrophil cytoplasm antibody-associated necrotizing vasculitides. (2013) (77)
- B cell activating factor is central to bleomycin- and IL-17-mediated experimental pulmonary fibrosis. (2015) (76)
- Mitochondria: An Organelle of Bacterial Origin Controlling Inflammation (2018) (76)
- Sjogren's syndrome is associated with and not secondary to systemic sclerosis. (2006) (76)
- Microparticle-induced release of B-lymphocyte regulators by rheumatoid synoviocytes (2009) (74)
- European League Against Rheumatism Sjögren's Syndrome Disease Activity Index and European League Against Rheumatism Sjögren's Syndrome Patient‐Reported Index: A Complete Picture of Primary Sjögren's Syndrome Patients (2013) (74)
- Safety and efficacy of anti-tumor necrosis factor α therapy in ten patients with recent-onset refractory reactive arthritis. (2011) (73)
- Comparative effectiveness of rituximab, abatacept, and tocilizumab in adults with rheumatoid arthritis and inadequate response to TNF inhibitors: prospective cohort study (2019) (73)
- Exposure to abatacept or rituximab in the first trimester of pregnancy in three women with autoimmune diseases (2013) (72)
- Evaluation of low-dose rituximab for the retreatment of patients with active rheumatoid arthritis: a non-inferiority randomised controlled trial (2013) (71)
- Nonpharmacological treatments in early rheumatoid arthritis: clinical practice guidelines based on published evidence and expert opinion. (2006) (71)
- Contribution of autoantibodies to the diagnosis and nosology of inflammatory muscle disease. (2006) (70)
- Diagnostic performance of temporal artery ultrasound for the diagnosis of giant cell arteritis: a systematic review and meta-analysis of the literature. (2019) (70)
- Association of transforming growth factor beta1 and tumor necrosis factor alpha polymorphisms with anti-SSB/La antibody secretion in patients with primary Sjögren's syndrome. (2004) (70)
- Safety and Efficacy of Rituximab in Severe Juvenile Dermatomyositis: Results from 9 Patients from the French Autoimmunity and Rituximab Registry (2011) (70)
- Recommendations of the French Society for Rheumatology regarding TNFalpha antagonist therapy in patients with rheumatoid arthritis. (2007) (70)
- Long-Term Rituximab Use to Maintain Remission of Antineutrophil Cytoplasmic Antibody–Associated Vasculitis (2020) (68)
- TNF alpha antagonist therapy and safety monitoring. (2011) (68)
- Masitinib in the treatment of active rheumatoid arthritis: results of a multicentre, open-label, dose-ranging, phase 2a study (2009) (67)
- Experience of intravenous immunoglobulin therapy in neuropathy associated with primary Sjögren's syndrome: A national multicentric retrospective study (2011) (66)
- Innate immunity triggers IL-32 expression by fibroblast-like synoviocytes in rheumatoid arthritis (2010) (66)
- Associated Autoimmune Diseases in Systemic Sclerosis Define a Subset of Patients with Milder Disease: Results from 2 Large Cohorts of European Caucasian Patients (2010) (66)
- Phenotype-Haplotype Correlation of IRF5 in Systemic Sclerosis: Role of 2 Haplotypes in Disease Severity (2010) (64)
- Etanercept in the Longterm Treatment of Patients With Ankylosing Spondylitis (2009) (64)
- Late-onset neutropenia after treatment with rituximab for rheumatoid arthritis and other autoimmune diseases: data from the AutoImmunity and Rituximab registry (2015) (64)
- Modern management of non-chemotherapy drug-induced agranulocytosis: a monocentric cohort study of 90 cases and review of the literature. (2002) (63)
- Development of the Sjögren's Syndrome Responder Index, a data-driven composite endpoint for assessing treatment efficacy. (2015) (62)
- Comparison of Certolizumab Pegol with Other Anticytokine Agents for Treatment of Rheumatoid Arthritis: A Multiple-treatment Bayesian Metaanalysis (2011) (62)
- Vaccination against COVID-19: Expectations and concerns of patients with autoimmune and rheumatic diseases (2021) (62)
- IFN-β-induced reactive oxygen species and mitochondrial damage contribute to muscle impairment and inflammation maintenance in dermatomyositis (2017) (62)
- Prediction of pulmonary hypertension related to systemic sclerosis by an index based on simple clinical observations. (2011) (61)
- Exploring necrotizing autoimmune myopathies with a novel immunoassay for anti-3-hydroxy-3-methyl-glutaryl-CoA reductase autoantibodies (2014) (61)
- Brief report: candidate gene study in systemic sclerosis identifies a rare and functional variant of the TNFAIP3 locus as a risk factor for polyautoimmunity. (2012) (61)
- Evaluation of a French version of the Bath Ankylosing Spondylitis Disease Activity Index in patients with spondyloarthropathy. (1997) (60)
- Efficacy and safety of rituximab in the treatment of refractory inflammatory myopathies in adults: results from the AIR registry. (2011) (60)
- Costs of rheumatoid arthritis in France: a multicenter study of 1109 patients managed by hospital-based rheumatologists. (2004) (60)
- Phenotypes Determined by Cluster Analysis and Their Survival in the Prospective European Scleroderma Trials and Research Cohort of Patients With Systemic Sclerosis (2019) (59)
- Abatacept therapy and safety management. (2009) (59)
- Anti-pm/scl antibodies in connective tissue disease: Clinical and biological assessment of 14 patients. (2006) (58)
- Presence of microchimerism in labial salivary glands in systemic sclerosis but not in Sjögren's syndrome. (2002) (57)
- Reactive arthritis or chronic infectious arthritis? (2002) (57)
- Rituximab Treatment for Spondyloarthritis. A Nationwide Series: Data from the AIR Registry of the French Society of Rheumatology (2012) (57)
- Association between an endoglin gene polymorphism and systemic sclerosis-related pulmonary arterial hypertension. (2006) (57)
- Bone and joint disease associated with primary immune deficiencies. (2005) (57)
- Detection of Borrelia burgdorferi DNA in muscle of patients with chronic myalgia related to Lyme disease. (1998) (57)
- Efficacy of anakinra in calcium pyrophosphate crystal-induced arthritis: a report of 16 cases and review of the literature. (2013) (57)
- The 2018 pipeline of targeted therapies under clinical development for Systemic Lupus Erythematosus: a systematic review of trials. (2018) (56)
- Tocilizumab: therapy and safety management. (2010) (56)
- Worldwide trends in all-cause mortality of auto-immune systemic diseases between 2001 and 2014. (2020) (55)
- Recommendations of the French Society for Rheumatology. TNFalpha antagonist therapy in rheumatoid arthritis. (2006) (55)
- HIBISCUS: Hydroxychloroquine for the secondary prevention of thrombotic and obstetrical events in primary antiphospholipid syndrome. (2018) (53)
- Independent replication establishes the CD247 gene as a genetic systemic sclerosis susceptibility factor (2011) (53)
- In Antisynthetase Syndrome, ACPA Are Associated With Severe and Erosive Arthritis (2015) (53)
- Use of Whole‐Blood Transcriptomic Profiling to Highlight Several Pathophysiologic Pathways Associated With Response to Rituximab in Patients With Rheumatoid Arthritis: Data From a Randomized, Controlled, Open‐Label Trial (2014) (53)
- MiR-30a-3p Negatively Regulates BAFF Synthesis in Systemic Sclerosis and Rheumatoid Arthritis Fibroblasts (2014) (52)
- Analysis of bacterial DNA in synovial tissue of Tunisian patients with reactive and undifferentiated arthritis by broad-range PCR, cloning and sequencing (2008) (52)
- C8orf13-BLK is a genetic risk locus for systemic sclerosis and has additive effects with BANK1: results from a large french cohort and meta-analysis. (2011) (51)
- Reporting of Harm in Randomized, Controlled Trials of Nonpharmacologic Treatment for Rheumatic Disease (2005) (51)
- Drug-induced systemic lupus: revisiting the ever-changing spectrum of the disease using the WHO pharmacovigilance database (2019) (51)
- Recommendations for using TNFα antagonists and French Clinical Practice Guidelines endorsed by the French National Authority for Health. (2013) (51)
- Efficacy of vinblastine in central nervous system Langerhans cell histiocytosis: a nationwide retrospective study (2011) (51)
- Personalized Physical Therapy Versus Usual Care for Patients With Systemic Sclerosis: A Randomized Controlled Trial (2017) (51)
- Rapid chondrolysis after an intra-articular leak of bone cement in treatment of a benign acetabular subchondral cyst: an unusual complication of percutaneous injection of acrylic cement (2000) (50)
- Cross Talk between MyD88 and Focal Adhesion Kinase Pathways1 (2005) (50)
- Physical examination and laboratory tests in the management of patients with rheumatoid arthritis: development of recommendations for clinical practice based on published evidence and expert opinion. (2005) (49)
- CCL19, a B cell chemokine, is related to the decrease of blood memory B cells and predicts the clinical response to rituximab in patients with rheumatoid arthritis. (2013) (49)
- Anti-TNF alpha therapy and safety monitoring. Clinical tool guide elaborated by the Club Rhumatismes et Inflammations (CRI), section of the French Society of Rheumatology (Société Française de Rhumatologie, SFR). (2005) (49)
- Erectile dysfunction is frequent in systemic sclerosis and associated with severe disease: a study of the EULAR Scleroderma Trial and Research group (2012) (49)
- Association of a KCNA5 gene polymorphism with systemic sclerosis-associated pulmonary arterial hypertension in the European Caucasian population. (2010) (49)
- Risk factors of serious infections in patients with rheumatoid arthritis treated with tocilizumab in the French Registry REGATE (2017) (49)
- ERK 1/2- and JNKs-dependent Synthesis of Interleukins 6 and 8 by Fibroblast-like Synoviocytes Stimulated with Protein I/II, a Modulin from Oral Streptococci, Requires Focal Adhesion Kinase* (2003) (48)
- Five-year Favorable Outcome of Patients with Early Rheumatoid Arthritis in the 2000s: Data from the ESPOIR Cohort (2013) (48)
- Disease Expression of Lyme Borreliosis in Northeastern France (2001) (48)
- Characteristics of patients with rheumatoid arthritis in France: a study of 1109 patients managed by hospital based rheumatologists (2004) (48)
- Etk/BMX, a Btk Family Tyrosine Kinase, and Mal Contribute to the Cross-Talk between MyD88 and FAK Pathways1 (2008) (47)
- Predictors of fatigue and severe fatigue in a large international cohort of patients with systemic lupus erythematosus and a systematic review of the literature. (2018) (47)
- Amyloid arthropathy in the course of multiple myeloma. (2002) (46)
- Local corticosteroid injections in the treatment of rotator cuff tendinitis (except for frozen shoulder and calcific tendinitis). Groupe Rhumatologique Français de l'Epaule (G.R.E.P.). (1996) (46)
- No evidence for an association between the -871 T/C promoter polymorphism in the B-cell-activating factor gene and primary Sjögren's syndrome (2006) (46)
- Rheumatologists’ Perceptions of Biosimilar Medicines Prescription: Findings from a French Web-Based Survey (2016) (46)
- Role and modalities of information and education in the management of patients with rheumatoid arthritis: development of recommendations for clinical practice based on published evidence and expert opinion. (2005) (44)
- Outcome of Hepatitis E Virus Infection in Patients With Inflammatory Arthritides Treated With Immunosuppressants (2015) (44)
- Seronegative polyarthritis revealing antisynthetase syndrome: a multicentre study of 40 patients. (2015) (44)
- Myocarditis in Patients With Antisynthetase Syndrome (2015) (44)
- Anti-Ku syndrome with elevated CK and anti-Ku syndrome with anti-dsDNA are two distinct entities with different outcomes (2019) (43)
- Health assessment questionnaire score is the best predictor of 5-year quality of life in early rheumatoid arthritis. (2006) (43)
- Retention rates of adalimumab, etanercept and infliximab as first and second-line biotherapy in patients with rheumatoid arthritis in daily practice. (2014) (43)
- Association between -871C>T promoter polymorphism in the B-cell activating factor gene and the response to rituximab in rheumatoid arthritis patients. (2013) (42)
- Lymphoproliferative disorders in rheumatoid arthritis patients on low-dose methotrexate. (1998) (42)
- Nonchemotherapy drug-induced agranulocytosis in elderly patients: the effects of granulocyte colony-stimulating factor. (2002) (42)
- Vaccinations in adults with chronic inflammatory joint disease: Immunization schedule and recommendations for patients taking synthetic or biological disease-modifying antirheumatic drugs. (2016) (41)
- Safety of Surgery After Rituximab Therapy in 133 Patients With Rheumatoid Arthritis: Data From the AutoImmunity and Rituximab Registry (2013) (41)
- Chest high resolution CT in adults with primary humoral immunodeficiency. (1996) (41)
- Rituximab in central nervous system manifestations of patients with primary Sjögren's syndrome: results from the AIR registry. (2012) (41)
- Broad-range PCR, cloning and sequencing of the full 16S rRNA gene for detection of bacterial DNA in synovial fluid samples of Tunisian patients with reactive and undifferentiated arthritis (2009) (41)
- Body mass index and response to tocilizumab in rheumatoid arthritis: a real life study (2016) (40)
- BAFF synthesis by rheumatoid synoviocytes is positively controlled by alpha5beta1 integrin stimulation and is negatively regulated by tumor necrosis factor alpha and Toll-like receptor ligands. (2007) (40)
- Knowledge, behaviors and practices of community and hospital pharmacists towards biosimilar medicines: Results of a French web-based survey (2017) (40)
- The usefulness of bone remodelling markers in predicting the efficacy of pamidronate treatment in SAPHO syndrome. (2006) (39)
- Prevalence of Autoantibodies to Cyclic Citrullinated Peptide in Patients with Rheumatic Diseases other than Rheumatoid Arthritis: A French Multicenter Study (2008) (39)
- Predictive risk factors of serious infections in patients with rheumatoid arthritis treated with abatacept in common practice: results from the Orencia and Rheumatoid Arthritis (ORA) registry (2015) (39)
- Knee joint arthroplasty in a patient with haemophilia A and high inhibitor titre using recombinant factor VIIa (NovoSeven®): a new case report and review of the literature (2001) (38)
- Primary Sjögren’s syndrome associated agranulocytosis: a benign disorder? (2003) (38)
- Mortality in systemic necrotizing vasculitides: A retrospective analysis of the French Vasculitis Study Group registry. (2018) (37)
- Independent Replication and Metaanalysis of Association Studies Establish TNFSF4 as a Susceptibility Gene Preferentially Associated with the Subset of Anticentromere-positive Patients with Systemic Sclerosis (2012) (37)
- A randomized, double blind, placebo controlled multicenter trial of murine anti-CD4 monoclonal antibody therapy in rheumatoid arthritis. (1998) (37)
- Structural evaluation in the management of patients with rheumatoid arthritis: development of recommendations for clinical practice based on published evidence and expert opinion. (2005) (37)
- [Interstitial granulomatous dermatitis and paraneoplastic rheumatoid polyarthritis disclosing cancer of the lung]. (1998) (37)
- Gene expression profiling in peripheral blood cells of patients with rheumatoid arthritis in response to anti-TNF-alpha treatments. (2011) (37)
- AA amyloidosis treated with tocilizumab: case series and updated literature review (2015) (36)
- Lack of efficacy of rituximab in Felty’s syndrome (2005) (36)
- Interleukin 6 receptor inhibition in primary Sjögren syndrome: a multicentre double-blind randomised placebo-controlled trial (2020) (36)
- Treatment resistant Lyme arthritis caused byBorrelia garinii (2001) (36)
- Refining “Long-COVID” by a Prospective Multimodal Evaluation of Patients with Long-Term Symptoms Attributed to SARS-CoV-2 Infection (2021) (35)
- Defensin is suppressed by tick salivary gland extract during the in vitro interaction of resident skin cells with Borrelia burgdorferi. (2009) (35)
- Comparison of tocilizumab as monotherapy or with add-on disease-modifying antirheumatic drugs in patients with rheumatoid arthritis and inadequate responses to previous treatments: an open-label study close to clinical practice (2015) (35)
- Prediction of response to disease modifying antirheumatic drugs in rheumatoid arthritis. (2010) (35)
- Rituximab: a new therapeutic alternative in rheumatoid arthritis. (2008) (34)
- High reactive oxygen species in fibrotic and nonfibrotic skin of patients with diffuse cutaneous systemic sclerosis. (2015) (34)
- Synovial fibroblasts promote immunoglobulin class switching by a mechanism involving BAFF (2011) (34)
- Lymphocyte Changes in Severe COVID-19: Delayed Over-Activation of STING? (2020) (34)
- ACE inhibitors in SSc patients display a risk factor for scleroderma renal crisis—a EUSTAR analysis (2020) (33)
- The Gap Between Practice and Guidelines in the Choice of First-line Disease Modifying Antirheumatic Drug in Early Rheumatoid Arthritis: Results from the ESPOIR Cohort (2009) (33)
- Mutations of the cystic fibrosis gene in patients with bronchiectasis associated with rheumatoid arthritis (2010) (33)
- Longterm Safety, Efficacy, and Inhibition of Structural Damage Progression Over 5 Years of Treatment with Abatacept in Patients with Rheumatoid Arthritis in the Abatacept in Inadequate Responders to Methotrexate Trial (2014) (31)
- Nail abnormalities in rheumatoid arthritis (1997) (30)
- Efficacy of Biological-Targeted Treatments in Takayasu ArteritisCLINICAL PERSPECTIVE (2015) (30)
- Pathogenic role of platelets in rheumatoid arthritis and systemic autoimmune diseases (2016) (30)
- Polymerase chain reaction testing for Tropheryma whippelii in unexplained isolated cases of arthritis. (2002) (30)
- Failure to confirm coxsackievirus infection in primary Sjögren's syndrome. (2006) (30)
- Significance of Diminished Factor XIII in Crohn's Disease (1998) (29)
- Heterogeneous clinical spectrum of anti-SRP myositis and importance of the methods of detection of anti-SRP autoantibodies: a multicentric study (2016) (29)
- Multicentric reticulohistiocytosis: an autoimmune systemic disease? Case report of an association with erosive rheumatoid arthritis and systemic Sjogren syndrome. (2010) (29)
- Association of hypoxia‐inducible factor 1A (HIF1A) gene polymorphisms with systemic sclerosis in a French European Caucasian population (2009) (29)
- [Understanding rheumatoid arthritis]. (2005) (29)
- Humoral immunity to SARS-CoV-2 and seasonal coronaviruses in children and adults in north-eastern France (2021) (29)
- Seminars in Arthritis and Rheumatism (2014) (29)
- Serious infusion-related reaction after rituximab, abatacept and tocilizumab in rheumatoid arthritis: prospective registry data (2017) (29)
- The pipeline of targeted therapies under clinical development for primary Sjögren's syndrome: A systematic review of trials. (2019) (28)
- Comment faire le diagnostic et mieux comprendre les myopathies inflammatoires ? L’utilité des auto-anticorps (2010) (28)
- MMP-3 expression and release by rheumatoid arthritis fibroblast-like synoviocytes induced with a bacterial ligand of integrin α5β1 (2004) (27)
- International and multidisciplinary expert recommendations for the use of biologics in systemic lupus erythematosus. (2017) (27)
- Cognitive Dysfunction and Dementia in Primary Sjögren's Syndrome (2013) (27)
- Structural analysis of human antibodies to proteinase 3 from patients with Wegener granulomatosis. (1997) (27)
- Impact of medical practices on the costs of management of rheumatoid arthritis by anti-TNFalpha biological therapy in France. (2005) (27)
- Total knee arthroplasty in severe haemophilic patients under continuous infusion of clotting factors (2012) (26)
- Inflammatory myopathies: A new landscape. (2018) (26)
- Postrehabilitation Functional Improvements in Patients With Inflammatory Myopathies: The Results of a Randomized Controlled Trial. (2017) (26)
- The IgG2 Isotype of Anti–Transcription Intermediary Factor 1γ Autoantibodies Is a Biomarker of Cancer and Mortality in Adult Dermatomyositis (2019) (25)
- Contribution of rare and predicted pathogenic gene variants to childhood-onset lupus: a large, genetic panel analysis of British and French cohorts (2020) (25)
- Diagnostic accuracy of intra-articular C-reactive protein assay in periprosthetic knee joint infection--a preliminary study. (2014) (25)
- Association Study of ITGAM, ITGAX, and CD58 Autoimmune Risk Loci in Systemic Sclerosis: Results from 2 Large European Caucasian Cohorts (2011) (25)
- Silent thyroiditis associated with etanercept in rheumatoid arthritis (2002) (25)
- Body mass index and response to abatacept in rheumatoid arthritis (2016) (25)
- Lupus Regulator Peptide P140 Represses B Cell Differentiation by Reducing HLA Class II Molecule Overexpression (2018) (25)
- Characteristics and clinical outcomes after treatment of a national cohort of PCR-positive Lyme arthritis. (2019) (24)
- Rituximab treatment overcomes reduction of regulatory iNKT cells in patients with rheumatoid arthritis. (2010) (24)
- Signification clinique des anticorps antiribosomes (2000) (24)
- Association of IL-2RA and IL-2RB genes with erosive status in early rheumatoid arthritis patients (ESPOIR and RMP cohorts). (2014) (23)
- Abatacept therapy and safety management. (2012) (23)
- Patient knowledge of their disease: a French multicenter study in ankylosing spondylitis. (2004) (23)
- A randomised, double-blind, placebo-controlled study assessing the efficacy of high doses of vitamin D on functional disability in patients with rheumatoid arthritis. (2018) (23)
- Advances in the treatment of systemic lupus erythematosus: From back to the future, to the future and beyond. (2019) (22)
- A mouse model of MSU-induced acute inflammation in vivo suggests imiquimod-dependent targeting of Il-1β as relevant therapy for gout patients (2020) (22)
- Which and How Many Patients Should Be Included in Randomised Controlled Trials to Demonstrate the Efficacy of Biologics in Primary Sjögren’s Syndrome? (2015) (22)
- A new MHC‐linked susceptibility locus for primary Sjögren's syndrome: MICA (2017) (22)
- CTLA-4 +49A/G and CT60 gene polymorphisms in primary Sjögren syndrome (2007) (21)
- Ro(SS-A) and anti-Ro(SS-A): an update. (1998) (21)
- Vaccination and rheumatoid arthritis (2002) (21)
- Treatment of systemic lupus erythematosus in 2006. (2006) (20)
- Systemic capillary leak syndrome and autoimmune diseases: A case series. (2017) (19)
- Hyper-IgM syndrome associated with rheumatoid arthritis: report of RA in a patient with primary impaired CD40 pathway. (1996) (19)
- Continuation of treatment with infliximab in ankylosing spondylitis: 2-yr open follow-up. (2006) (19)
- Bone and joint infection due to Streptococcus pneumoniae in two immunocompetent adults. (2006) (19)
- Peripheral blood lymphocytes from patients with rheumatoid arthritis are differentially sensitive to apoptosis induced by anti-tumour necrosis factor-alpha therapy. (2008) (19)
- A new defensive mechanism to prevent apoptosis in salivary ductal cells from patients with Sjögren's syndrome: over-expression of p53 and p21. (2002) (18)
- Patient acceptable symptom state and minimal clinically important difference for patient-reported outcomes in systemic sclerosis: A secondary analysis of a randomized controlled trial comparing personalized physical therapy to usual care. (2019) (18)
- Jessner–Kanof disease induced by leflunomide: a dermal variant of cutaneous lupus? (2011) (18)
- Targeting the splicing of mRNA in autoimmune diseases: BAFF inhibition in Sjögren's syndrome as a proof of concept. (2014) (18)
- Le rituximab : une biothérapie originale dans les maladies auto-immunes (2005) (18)
- T1 mapping cardiac magnetic resonance imaging frequently detects subclinical diffuse myocardial fibrosis in systemic sclerosis patients. (2020) (18)
- Anti-p53 antibodies are rarely detected in serum of patients with rheumatoid arthritis and Sjögren's syndrome. (1999) (17)
- Factors linked to disease activity in a French cohort of patients with spondyloarthropathy. (1998) (17)
- Idiosyncratic drug-induced neutropenia and agranulocytosis (2017) (17)
- Efficacy of abatacept in systemic lupus erythematosus: a retrospective analysis of 11 patients with refractory disease (2016) (17)
- Pancytopenia secondary to hemophagocytic syndrome in rheumatoid arthritis treated with methotrexate and sulfasalazine. (1998) (17)
- Bone mineral density changes after 2 years of ARV treatment, compared to naive HIV-1-infected patients not on HAART (2015) (17)
- Reactive and undifferentiated arthritis in North Africa: use of PCR for detection of Chlamydia trachomatis (2008) (17)
- Novel concepts and treatments for autoimmune disease: ten focal points. (2004) (17)
- Cluster analysis reveals 3 main patterns of behavior towards SARS-CoV-2 vaccination in patients with autoimmune and inflammatory diseases (2021) (17)
- Idiosyncratic drug-induced neutropenia & agranulocytosis. (2017) (17)
- Anti-α-fodrin autoantibodies are not useful diagnostic markers of primary Sjögren’s syndrome (2005) (16)
- Polymorphic markers of the fibrillin-1 gene and systemic sclerosis in European Caucasian patients. (2008) (16)
- [Corticosteroids and inflammation]. (2003) (16)
- Patterns of fatigue and association with disease activity and clinical manifestations in systemic lupus erythematosus. (2020) (16)
- Long-term efficacy and safety of antitumour necrosis factor alpha treatment in rhupus: an open-label study of 15 patients (2017) (16)
- Reduced DICER1 Expression Bestows Rheumatoid Arthritis Synoviocytes Proinflammatory Properties and Resistance to Apoptotic Stimuli (2016) (16)
- Idiosyncratic Drug-Induced Severe Neutropenia and Agranulocytosis in Elderly Patients (≥75 years): A Monocentric Cohort Study of 61 Cases (2016) (16)
- Réactions cutanées paradoxales sous traitement par tocilizumab (2014) (15)
- Muscle fluorodeoxyglucose uptake assessed by positron emission tomography-computed tomography as a biomarker of inflammatory myopathies disease activity. (2019) (15)
- Safety of surgery in patients with rheumatoid arthritis treated by abatacept: data from the French Orencia in Rheumatoid Arthritis Registry (2017) (15)
- Cervico-cranial artery dissection and antiphospholipid syndrome: is there a link? (2004) (15)
- Les facteurs de croissance hématopoïétique ont-ils une place dans le traitement des agranulocytoses médicamenteuses?* (2000) (15)
- Impact of gender on the response and tolerance to abatacept in patients with rheumatoid arthritis: results from the ‘ORA’ registry (2017) (15)
- Rampant infections of bone marrow stem cell niches as triggers for spondyloarthropathies and rheumatoid arthritis. (2016) (14)
- Homozygosity for the V377I mutation in mevalonate kinase causes distinct clinical phenotypes in two sibs with hyperimmunoglobulinaemia D and periodic fever syndrome (HIDS) (2016) (14)
- Conseils d’utilisation des traitements anti-TNF et recommandations nationales de bonne pratique labellisées par la Haute Autorité de santé française☆☆☆ (2013) (14)
- Brief Report: Spatial Heterogeneity of Systemic Sclerosis in France: High Prevalence in the Northeast Region (2016) (14)
- Primary humoral immunodeficiency (late-onset common variable immunodeficiency) with antinuclear antibodies and selective immunoglobulin deficiency. (2001) (14)
- Variants of genes implicated in type 1 interferon pathway and B-cell activation modulate the EULAR response to rituximab at 24 weeks in rheumatoid arthritis (2017) (14)
- Nocardia discitis in an immunocompetent patient. (2007) (14)
- Gonadotrophin-releasing hormone agonists induce osteoporosis. (1994) (14)
- Mechanics hands in patients with antisynthetase syndrome: 25 cases. (2019) (14)
- Clinical and immunological features of antiphospholipid syndrome in the elderly: a retrospective national multicentre study. (2019) (13)
- Rituximab et traitement des maladies auto-immunes et inflammatoires systémiques (2009) (13)
- Multi-OMICS analyses unveil STAT1 as a potential modifier gene in mevalonate kinase deficiency (2018) (13)
- Drug-induced agranulocytosis in older people. A case series of 25 patients. (1999) (13)
- Prise en charge des ulcères digitaux de la sclérodermie systémique : Recommandations d’un groupe pluridisciplinaire d’experts (2008) (13)
- Les lupus induits par les médicaments (2002) (13)
- [How can we diagnose and better understand inflammatory myopathies? The usefulness of auto-antibodies]. (2010) (13)
- Refining myositis associated with primary Sjögren's syndrome: data from the prospective cohort ASSESS. (2020) (13)
- DICER1: A Key Player in Rheumatoid Arthritis, at the Crossroads of Cellular Stress, Innate Immunity, and Chronic Inflammation in Aging (2018) (13)
- Therapeutic Modulation of Plasmacytoid Dendritic Cells in Experimental Arthritis (2017) (13)
- Exacerbation of systemic lupus erythematosus after hepatitis B vaccination: comment on the article by Battafarano et al and the letter by Senécal et al. (2000) (13)
- Association of Metalloproteinase Gene Polymorphisms with Systemic Sclerosis in the European Caucasian Population (2010) (12)
- Comparative effect of tumour necrosis factor inhibitors versus other biological agents on cardiovascular risk-associated biomarkers in patients with rheumatoid arthritis (2019) (12)
- Angiotensin-Converting Enzyme Gene Does Not Contribute to Genetic Susceptibility to Systemic Sclerosis in European Caucasians (2009) (12)
- Granulomatosis-associated myositis (2019) (12)
- Incidence of paradoxical reactions in patients treated with tocilizumab for rheumatoid arthritis: Data from the French registry REGATE. (2018) (12)
- Nailfold capillary abnormalities in erectile dysfunction of systemic sclerosis: a EUSTAR group analysis. (2014) (12)
- Use of bosentan for digital ulcers related to systemic sclerosis: a real-life retrospective French study of 89 patients treated since specific approval (2014) (12)
- Trained Immunity and Autoimmune Disease: Did Eve Sin before Adam? (2019) (12)
- Whipple limbic encephalitis. (2011) (12)
- OP0065 Tolerance and efficacy of rituximab in primary sjogren syndrome (TEARS): Results of a randomized controlled trial (2013) (12)
- Multiple fluid-filled bone metastases. (2010) (12)
- [Treatment of systemic autoimmune and inflammatory diseases with rituximab]. (2009) (12)
- Pro-inflammatory cytokine production by synoviocytes following exposure to protein I/II, a modulin from oral streptococci. (2001) (12)
- B-cell targeted therapy is associated with severe COVID-19 among patients with inflammatory arthritides: a 1-year multicentre study in 1116 successive patients receiving intravenous biologics (2021) (12)
- Survival in the rheumatoid synovium. (2011) (11)
- Cellular magnetic resonance imaging for the differentiation of infectious and degenerative vertebral disorders: Preliminary results (2009) (11)
- [Macrophage activation syndrome in lupus]. (1993) (11)
- [Digestive and hemorrhage complications of low-dose aspirin]. (2003) (11)
- Biosimilar infliximab for the management of rheumatoid arthritis in France: what are the expected savings? (2016) (11)
- Association between RANK, RANKL and OPG polymorphisms with ACPA and erosions in rheumatoid arthritis: results from a meta-analysis involving three French cohorts (2016) (11)
- Neonatal management of symptomatic transplacental cryoglobulinaemia (2004) (11)
- Gemcitabine-induced myopathy. (2014) (10)
- Anti-{alpha}-fodrin autoantibodies are not useful diagnostic markers of primary Sjögren's syndrome. (2005) (10)
- Spondylarthrite ankylosante et autres spondylarthropathies (2005) (10)
- An arthro-dermato-pulmonary syndrome associated with anti-MDA5 antibodies. (2014) (10)
- Les manifestations rhumatologiques de la borréliose de Lyme (2002) (10)
- Anticorps sériques circulants dirigés contre des antigènes modifiés par le NO dans les affections neurologiques et rhumatismales (1998) (10)
- Eosinophilic myositis as first manifestation in a patient with type 2 myotonic dystrophy CCTG expansion mutation and rheumatoid arthritis (2015) (10)
- Improvement in patient-reported outcomes after rituximab in rheumatoid arthritis patients: An open-label assessment of 175 patients. (2015) (10)
- Impaired release of IL‐18 from fibroblast‐like synoviocytes activated with protein I/II, a pathogen‐associated molecular pattern from oral streptococci, results from defective translation of IL‐18 mRNA in pro‐IL‐18 (2004) (10)
- Evaluation of the impact of a nurse-led program of patient self-assessment and self-management in axial spondyloarthritis: results of a prospective, multicentre, randomized, controlled trial (COMEDSPA). (2020) (10)
- [Autoantibodies, diagnostic and prognostic markers of rheumatoid polyarthritis]. (2000) (10)
- [Paradoxical cutaneous reactions associated with tocilizumab therapy]. (2014) (10)
- Association study of 3 rheumatoid arthritis risk loci in systemic sclerosis in European Caucasian population. (2011) (10)
- Severe atherosclerosis in rheumatoid arthritis and hyperhomocysteinemia: is there a link? (2008) (10)
- Psoriasis: skin and joints, same fight? (2006) (10)
- The relapsing polychondritis damage index (RPDAM): Development of a disease-specific damage score for relapsing polychondritis. (2019) (9)
- Skeletal recovery from hepatitis C-associated osteosclerosis (HCAO) following antiviral treatment. (2011) (9)
- Acute hepatitis E during biotherapy. (2013) (9)
- Campylobacter fetus infection in three rheumatoid arthritis patients treated with rituximab (2012) (9)
- Autoantibodies and human immunodeficiency viruses infection: a case-control study. (2003) (9)
- Tolerance and efficacy of rituximab in primary Sjögren syndrome (TEARS): results of the randomized controlled trial. (2012) (9)
- Candidate Gene Study in Systemic Sclerosis Identifies a Rare and Functional Variant of the TNFAIP 3 Locus as a Risk Factor for Polyautoimmunity (2012) (9)
- Place et forme de l'information et de l'éducation dans la prise en chargede personnes souffrant de polyarthrite rhumatoïde établissement de recommandations pour la pratique clinique à partir de données de la littérature et d'opinions d'experts (rencontres d'experts en rhumatologie) (2004) (9)
- Shared development of targeted therapies among autoimmune and inflammatory diseases: a systematic repurposing analysis (2020) (9)
- Therapeutic Perspectives for Interferons and Plasmacytoid Dendritic Cells in Rheumatoid Arthritis. (2018) (9)
- Hydroxychloroquine levels in patients with systemic lupus erythematosus: whole blood is preferable but serum levels also detect non-adherence (2020) (9)
- Evaluation of two strategies (initial methotrexate monotherapy versus its combination with adalimumab) in management of early active rheumatoid arthritis during the first year of evolution: Data from 3 the Guepard trial (2008) (9)
- Primary Sjögren's syndrome and vitamin B12 deficiency: preliminary results in 80 patients. (2006) (9)
- Prévention des infections au cours du lupus systémique chez l’adulte et l’adolescent : élaboration de recommandations pour la pratique clinique, à partir d’une analyse de la littérature et de l’avis d’experts (2016) (9)
- One-Step Reverse Transcriptase PCR Method for Detection of Borrelia burgdorferi mRNA in Mouse Lyme Arthritis Tissue Samples (1999) (9)
- Methotrexate treatment and mortality in rheumatoid arthritis. Authors' reply (2002) (8)
- Evaluation of the impact of a nurse-led program of systematic screening of comorbidities in patients with axial spondyloarthritis: The results of the COMEDSPA prospective, controlled, one year randomized trial. (2020) (8)
- And if we had to do it all over again, would we send medical students to the emergency departments during a pandemic? Lessons learned from the COVID-19 outbreak (2021) (8)
- Safety of surgery in patients with rheumatoid arthritis treated with tocilizumab: data from the French (REGistry -RoAcTEmra) Regate registry. (2020) (8)
- Étude de l’impact d’un processus de conciliation thérapeutique dans un service de rhumatologie hospitalo-universitaire : rôle et intérêt d’un pharmacien clinicien dans une équipe soignante (2015) (8)
- Systemic lupus erythematosus and neutropaenia: a hallmark of haematological manifestations (2020) (8)
- THE HISTORY OF LUPUS THROUGHOUT THE AGES. (2020) (8)
- Safety and efficacy of low-dose intravenous arsenic trioxide in systemic lupus erythematosus: an open-label phase IIa trial (Lupsenic) (2021) (8)
- Dépistage et prise en charge du risque cardiovasculaire au cours du lupus systémique : élaboration de recommandations pour la pratique clinique, à partir d’une analyse de la littérature et de l’avis d’experts (2015) (8)
- Combined search for anti-beta2-glycoprotein I and anticardiolipin antibodies in antiphospholipid syndrome: contribution to diagnosis. (2004) (8)
- [Risk factors for gastrointestinal bleeding associated with low-dose aspirin]. (2003) (8)
- Online Training on Skin Cancer Diagnosis in Rheumatologists: Results from a Nationwide Randomized Web-Based Survey (2015) (8)
- Association between-871 C > T promoter polymorphism in the B-cell activating factor gene and the response to rituximab in rheumatoid arthritis patients (2013) (7)
- Enhanced culture of Borrelia garinii and Borrelia afzelii strains on a solid BSK-based medium in anaerobic conditions. (2006) (7)
- Are Immunoglobulin A Anti-gliadin Antibodies Helpful in Diagnosing Coeliac Disease in Children Younger Than 2 Years? (2012) (7)
- Growing up with chronic arthritis: the confusing matter of classification (2017) (7)
- Systemic sclerosis overlap and non-overlap syndromes share clinical characteristics but differ in prognosis and treatments. (2020) (7)
- Successful management of neonatal cryoglobulinaemia after a gemellar pregnancy in a woman with symptomatic type I cryoglobulinaemia (2004) (7)
- FRI0323 Prospective Follow-Up of Tocilizumab Treatment in 1503 Patients with Refractory Rheumatoid Arthritis: Tolerance Data at 1 Year from the French Registry Regate (Registry – Roactemra) (2013) (7)
- Incidence and risk factors for gangrene in patients with systemic sclerosis from the EUSTAR cohort. (2019) (7)
- Infliximab is an effective glucocorticoid-sparing treatment for Takayasu arteritis: Results of a multicenter open-label prospective study. (2020) (7)
- Reducing the initial number of rituximab maintenance-therapy infusions for ANCA-associated vasculitides: randomized-trial post-hoc analysis. (2020) (7)
- Protéine de fusion ou anticorps monoclonal - Quel biomédicament choisir dans une maladie inflammatoire ? (2009) (7)
- Classification criteria and treatment modalities in primary Sjögren’s syndrome (2014) (7)
- Le traitement des spondylodiscites infectieuses non tuberculeuses. Analyse des pratiques thérapeutiques chez 110 patients hospitalisés dans 12 CHU en France (2001) (7)
- [Acrosyndromes induced by bleomycin in HIV 1 related Kaposi's disease. 5 cases]. (1997) (7)
- [Screening and management of cardiovascular risk factors in systemic lupus erythematosus: Recommendations for clinical practice based on the literature and expert opinion]. (2015) (6)
- Strategy for suspected myositis. (2019) (6)
- Immunosuppressive agents for rheumatoid arthritis: a systematic review of clinical trials and their current development stage (2020) (6)
- Which patients with rheumatoid arthritis, spondyloarthritis, or juvenile idiopathic arthritis receive TNF-α antagonists in France? The CORPUS cohort study. (2015) (6)
- [Pseudotumoral aspect of stress fracture of the pubis]. (1989) (6)
- A case of intracranial dural arteriovenous fistula draining into the spinal medullary veins. (1999) (6)
- [Prevention of infections in adults and adolescents with systemic lupus erythematosus: Guidelines for the clinical practice based on the literature and expert opinion]. (2016) (6)
- Current favourable 10-year outcome of patients with early rheumatoid arthritis: data from the ESPOIR cohort. (2021) (6)
- Que connat-on de la toxicit cardiovasculaire des AINS? (2006) (6)
- Biothérapies : évolution ou révolution ? (2006) (6)
- Comment définir et classer les maladies inflammatoires (2007) (6)
- [Rituximab: a original biotherapy in auto-immune disorders]. (2005) (5)
- [Management of digital ulcers from systemic scleroderma]. (2008) (5)
- SPONDYLARTHROPATHIE A DEBUT TARDIF ? RS3PE ? FORME DE CHEVAUCHEMENT ? (1991) (5)
- Le syndrome d'activation macrophagique au cours du lupus (1993) (5)
- OP0284 Impact of a Nurse Led Program of Patient Self-Assessment of Disease Activity on the Management of Rheumatoid Arthritis: Results of a Prospective, Multicentre, Randomized, Controlled Trial (Comedra) (2013) (5)
- Diagnostic uncertainty and clinical decision-making strategies. (2017) (5)
- History and Outcome of Febrile Neutropenia Outside the Oncology Setting: A Retrospective Study of 76 Cases Related to Non-Chemotherapy Drugs (2017) (5)
- Practical management of patients on Janus kinase inhibitor (JAKi) therapy: Practical fact sheets drawn up by the Rheumatism and Inflammation Club (CRI), a group endorsed by the French Society for Rheumatology (SFR). (2019) (5)
- Recurrent psoriatic onychoperiostitis induced by hydroxychloroquine. (1995) (5)
- Immune-mediated necrotizing myopathies are serologically heterogeneous and autoantibodies may predict their clinical phenotype: two cases associated with anti-Pl7 antibodies (2014) (5)
- Prescription strategy of antimalarials in cutaneous and systemic lupus erythematosus: an international survey (2021) (5)
- Treatment of active rheumatoid arthritis: comparison of patients younger vs older than 75 years (CORPUS cohort) (2018) (5)
- Immunothérapies du lupus systémique : innovations et perspectives (2005) (5)
- When biologics should be used in systemic lupus erythematosus? (2014) (5)
- Seasonal effect on fatigue, pain and dryness in primary Sjögren’s syndrome (2020) (5)
- Recommandations de la Société française de rhumatologie pour l'utilisation des agents anti-TNFα chez les personnes souffrant de polyarthrite rhumatoïde (2006) (5)
- Clinical spectrum and therapeutic management of auto-immune myelofibrosis: a nation-wide study of 30 cases. (2020) (5)
- Evaluation of Humoral Immunity to SARS-CoV-2: Diagnostic Value of a New Multiplex Addressable Laser Bead Immunoassay (2020) (5)
- [Painful edema of the feet revealing ankylosing spondylitis]. (2002) (5)
- Anti-pseudo-PCNA type 1 (anti-SG2NA) pattern: Track down Cancer, not SLE. (2016) (5)
- AB0007 Shared genetic predisposition in rheumatoid arthritis–interstitial lung disease and familial pulmonary fibrosis (2017) (5)
- Cardiovascular events and change in cholesterol levels in patients with rheumatoid arthritis treated with tocilizumab: data from the REGATE Registry. (2020) (5)
- Quels examens biologiques non immunologiques sont nécessaires pour éliminer une origine infectieuse ou microcristalline dans les rhumatismes inflammatoires débutants sans signe clinique d'orientation ? (2002) (5)
- Long-term safety and effectiveness of tocilizumab in patients with rheumatoid arthritis and inadequate responses to csDMARDs and/or TNF inhibitors: an open-label study close to clinical practice (2019) (4)
- LONG TERM EFFICACY AND SAFETY OF ETANERCEPT IN PATIENTS WITH ANKYLOSING SPONDYLITIS: 148 TO 160 WEEK ANALYSIS FROM AN ONGOING EU TRIAL: 215 (2006) (4)
- Lu.62Etude de la réponse immunitaire au vaccin anti-grippal chez les patients ayant une polyarthrite rhumatoïde et traités par abatacept (2007) (4)
- Clinical and Serological Features of Sjogren Syndrome in Patients with Rheumatoid Arthritis (2015) (4)
- Effets de la kétamine administrée par voie veineuse pendant trois jours sur les douleurs de fibromyalgie (2005) (4)
- What should be done in case of persistent symptoms after adequate antibiotic treatment for Lyme disease? (2009) (4)
- Perioperative Management of Patients with Rheumatoid Arthritis Treated with TNF-a Blocking Agents (2007) (4)
- Le rituximab: une nouvelle possibilit thrapeutique dans la polyarthrite rhumatode (2008) (4)
- Rituximab for rheumatoid arthritis-associated large granular lymphocytic leukemia, a retrospective case series. (2020) (4)
- Nouveaux autoanticorps de la polyarthrite rhumatoïde : les autoanticorps anti-peptides ou protéines citrullinées et les autres (2008) (4)
- [New autoanti-bodies in rheumatoid arthritis: anti-citrullinated protein or peptide autoanti-bodies and the others]. (2008) (4)
- OP0035 Tolerance of Rituximab, Abatacept and Tocilizumab in Common Practice: Analysis of the 3 Registries of the French Society of Rheumatology (Air, Ora and Regate) (2015) (4)
- Significance of Sjögren's syndrome and anti-cN1A antibody in myositis patients. (2021) (4)
- Actualités et perspectives thérapeutiques du lupus systémique (2008) (4)
- Destructive gouty arthritis of the hip. (1997) (4)
- Abatacept (CTLA4Ig) treatment increases the remission rate in rheumatoid arthritis patients refractory to methotrexate treatment (2004) (4)
- Immunotherapy of inflammatory diseases, 2005 (2005) (4)
- Incidence and predictors of COVID-19 and flares in patients with rare autoimmune diseases: a systematic survey and serological study at a national reference center in France (2021) (4)
- [Arthritis of the shoulder]. (1999) (4)
- [Drug-induced osteopathies]. (1999) (4)
- Population‐based prevalence of eosinophilic fasciitis (Shulman syndrome): a capture–recapture study (2018) (4)
- Acute pancreatitis in rheumatoid arthritis: causes. (2014) (4)
- Critères diagnostiques du syndrome de Gougerot-Sjögren (2013) (4)
- Aspects immunologiques du syndrome des antiphospholipides (2012) (4)
- Stratégie de prévention des complications gastro-duodénales chez les patients traités par aspirine à faible dose (2004) (4)
- Antiphospholipid syndrome: why and how should we make the diagnosis? (2003) (3)
- THU0087 One single infusion of rituximab 1g might be sufficient in the long-term management of rheumatoid arthritis patients responding to a first cycle of rituximab (2 × 1g): Results of a 2-year multi-center randomized controlled trial (2013) (3)
- THU0173 Retention Rates of Adalimumab, Etanercept and Infliximab as First and Second-Line Biologic Therapy in Patients with Rheumatoid Arthritis in Daily Practice: The Maintain Study (2013) (3)
- [Infectious osteoarthritis of the pubis in sportmen. Apropos of 2 cases]. (1993) (3)
- Atrial fibrillation in patients treated with intravenous zoledronic or pamidronic acid: a pharmacoepidemiological study. (2021) (3)
- THU0165 New Onset Vitiligo under Biological Agents: A CASE Series (2014) (3)
- Erratum: Prediction of pulmonary hypertension related to systemic sclerosis by an index based on simple clinical observations (Arthritis & Rheumatism (2790-2796)) (2011) (3)
- Ostéoarthrite infectieuse du pubis chez le sportif : à propos de deux observations (1993) (3)
- Biomarkers in Rheumatoid Arthritis (2014) (3)
- Anti-tNF et risque de néoplasie solide (2005) (3)
- Acrosyndromes induits par la bléomycine au cours de la maladie de Kaposi associée au VIH 1 : 5 observations (1997) (3)
- Interventional radiology and artificial intelligence in radiology: Is it time to enhance the vision of our medical students? (2020) (3)
- Système antigénique Ro/SSA et les anticorps anti-Ro/SSA en 1997 (1998) (3)
- Les médicaments biosimilaires : quels enjeux pour les professionnels de santé ? (2016) (3)
- Les nouvelles myopathies inflammatoires (2017) (3)
- OP0114 Inefficacy of Hydroxychoroquine in Primary Sjögren’s Syndrome: Results at 12 Months of the Randomized Placebo-Controlled Trial of Plaquenil in Primary Sjögren’s Syndrome (2013) (3)
- Association study of CRP gene in systemic sclerosis in European Caucasian population (2014) (3)
- Sarcoidosis in Patients with Antisynthetase Syndrome: Presentation and Outcome (2018) (3)
- DETECTION D'ADN DE BORRELIA BURGDORFERI PAR AMPLIFICATION GENIQUE DANS LE MUSCLE D'UN PATIENT ATTEINT DE FIBROMYALGIE (1995) (3)
- Agranulocytoses médicamenteuses en rhumatologie : étude rétrospective de 12 cas (2007) (3)
- Glucocorticoid-sparing effect of first-year anti-TNFα treatment in rheumatoid arthritis (CORPUS Cohort). (2017) (3)
- [Clinical significance of antiribosomal antibodies. Study Group on Autoimmunity (GEAI)]. (2000) (3)
- OP0234 Impact of a Nurse Led Program on the Management of Comorbidities in Rheumatoid Arthritis (RA). Results of a Prospective, Multicentre, Randomized, Controlled Trial (Comedra) (2013) (3)
- Réaction anaphylactoïde per-opératoire au cours d'une mastocytose systémique. (1994) (3)
- Universalis Calcinosis in Adult Dermatomyositis: An "Anti-NXP2 Syndrome". (2016) (3)
- [Rheumatologic manifestations of Lyme borreliosis]. (2002) (3)
- Les complications digestives et hémorragiques de l'aspirine à faible dose (2003) (3)
- [Prevention of gastroduodenal complications in patients taking low-dose aspirin]. (2004) (2)
- De nouvelles cibles cytokiniques dans la polyarthrite rhumatoïde : le tocilizumab et les autres inhibiteurs des cytokines (2010) (2)
- Sclérodermie systémique première partie classification, physiopathologie et pronostic (2004) (2)
- [Biological therapies: evolution or revolution?]. (2006) (2)
- Surveillance et précautions à prendre lors d’un traitement par un immunomodulateur biologique (2010) (2)
- Is Sarcoid Dactylitis Worse Than We ExPEcT? (2016) (2)
- [Scaphoid fissure in algodystrophy: diagnostic value of MRI]. (1994) (2)
- Myelopathy in Sjögren's syndrome: a causative role for cobalamin (vitamin B12) deficiency. (2006) (2)
- Les bolus de glucocorticoïdes dans la polyarthrite rhumatoïde (2001) (2)
- [The experience of anti-TNF-alpha registries and observatories]. (2010) (2)
- Naissance et développement de l'immunothérapie ciblée : la révolution des biomédicaments (2008) (2)
- FRI0329 Efficacy and safety of infliximab originator in patients with takayasu arteritis within the RTU (temporary recommendation of use) in france (2017) (2)
- Déficits immunitaires primitifs (2009) (2)
- Muscle MRI: All that glitters is not myositis. (2016) (2)
- FRI0154 Incidence of Cancers in Patients with Rheumatoid Arthritis and a History of Cancer Treated with Rituximab or Abatacept (2015) (2)
- Fatal Aspergillus fumigatus Myositis in an Immunocompetent Patient (2001) (2)
- AB0848 Rituximab treatment for spondyloarthritis. A nationwide series: Data from the air registry (2013) (2)
- L’expérience des registres et des observatoires anti-TNF-α (2010) (2)
- Agreement of Mexican rheumatologists with the ASsessment in Ankylosing Spondylitis International Working Group and the EUropean League Against Rheumatism recommendations for the management of ankylosing (2006) (2)
- FRI0126 Patients’ concerns about and perception of biosimilars in rheumatology : a french survey (2018) (2)
- [Epiphysis-metaphysis bone ischemia in hemorrhagic rectocolitis and Crohn's disease]. (1998) (2)
- [Detection of Borrelia burgdorferi DNA by gene amplification in the muscle of a patient with fibromyalgia]. (1995) (2)
- Auto-anticorps : intérêt diagnostique et pronostique en réanimation médicale (2002) (2)
- Syndrome des antiphospholipides : pourquoi faut-il y penser et comment faire le diagnostic ? (2003) (2)
- Prevalence of the different types of pulmonary hypertension in systemic sclerosis: Results from two large samples of European Caucasians And meta-analysis of five studies. (2010) (2)
- [Systemic lupus erythematosus: news and therapeutic perspectives]. (2008) (2)
- OP0135 Interferon-Beta Induced Reactive Oxygen Species Participate in Muscle Inflammation and Mitochondrial Oxydative Phosphorilation Defects Contributing to Dermatomyositis Muscle Impairement (2015) (2)
- THU0122 Safety of surgery in patients with rheumatoid arthritis treated by rituximab in routine care: Data from the french air registry (2013) (2)
- Perioperative management of patients with rheumatoid arthritis treated with TNF-alpha blocking agents. (2007) (2)
- FRI0179 Comparison of tocilizumab as monotherapy or in combination with non-biological disease-modifying anti-rheumatic drugs (DMARDs) in patients with rheumatoid arthritis (RA) and an inadequate response to anti-TNF agents (2013) (2)
- La cohorte espoir : un suivi de dix ans des arthrites débutantes en France. Méthodologie et caractéristiques initiales des 813 patients inclus (2007) (2)
- Effets indésirables rhumatologiques des quinolones (1992) (2)
- Borrelia burgdorferi in Lyme arthritis and undifferentiated arthritis. (1999) (2)
- MMP-3 expression and release by rheumatoid arthritis fibroblast-like synoviocytes induced with a bacterial ligand of integrin alpha5beta1 (2020) (2)
- Thoracoscopic sympathectomy for ischaemic lesions related to bleomycin therapy for acquired immune deficiency syndrome-related Kaposi's sarcoma. (1999) (2)
- Influence des pratiques médicales sur les coûts de traitement de la polyarthrite rhumatoïde par biothérapie anti-TNFα en France (2005) (2)
- Candida albicans vertebral osteomyelitis treated successfully with fluconazole (1997) (2)
- [Immunological aspects of the antiphospholipid syndrome]. (2012) (2)
- Unusual heel pain in a patient with primary oxalosis treated by liver-kidney transplantation. (1998) (2)
- In the idiopathic inflammatory myopathies, reactive oxygen species are at the crossroad between immune and non-immune cell-mediated mechanisms (2015) (2)
- NKG2D ligands in inflammatory joint diseases: analysis in human samples and mouse models. (2020) (2)
- Les effets des régimes et des stratégies diététiques dans la polyarthrite rhumatoïde (2015) (2)
- Arthrites réactionnelles ou arthrites infectieuses chroniques (1999) (2)
- Traitements immunosuppresseurs : modes d'administration, complications, mesures prophylactiques (2006) (2)
- Myelopathy in Sjögren’s Syndrome (2012) (2)
- Gene expression profiling in peripheral blood cells of patients with rheumatoid arthritis in response to anti-TNF- (cid:1) treatments (2011) (2)
- AB0593 Predictors of fatigue and severe fatigue in a large multicenter international cohort of patients with systemic lupus erythematosus: the fatilup study (2018) (1)
- Methotrexate treatment and mortality in rheumatoid arthritis (2002) (1)
- Pulmonary arterial hypertension during systemic lupus. (2012) (1)
- Une athéromatose sévère au cours d'une polyarthrite rhumatoïde : rôle de l'hyperhomocystéinémie ? (2008) (1)
- OP0253 WORLDWIDE TRENDS IN MORTALITY OF SYSTEMIC LUPUS ERYTHEMATOSUS BETWEEN 2000 AND 2015: ANALYSIS OF THE WORLD HEALTH ORGANIZATION DATABASE (2019) (1)
- Comment définir et classer les maladies inflammatoires ? How to define and to classify inflammatory systemic diseases ? (2007) (1)
- Le syndrome des antiphospholipides (SAPL): Aspects cliniques, diagnostiques et thérapeutiques (2002) (1)
- Leucoencéphalopathie au cours d'un lupus érythémateux systémique (2004) (1)
- Le renouveau de l'IL-1 et des anti-IL-1 (2009) (1)
- Autoévaluations de l'article : Traitements immunomodulateurs et immunosuppresseurs dans les maladies inflammatoires et auto-immunes (2018) (1)
- STRATEGIE DIAGNOSTIQUE DANS LES MALADIES AUTO-IMMUNES : INTERET DES AUTO-ANTICORPS (1998) (1)
- AB0475 Biologics in Monotherapy in rheumatoid Arthritis: A Multicentric Restrospective Study of 109 Patients (2015) (1)
- FRI0114 Diagnostic value of nucleosome-specific antibodies in recent active non treated sle (2001) (1)
- Amélioration des résultats rapportés par les patients atteints de polyarthrite rhumatoïde traités par rituximab : évaluation ouverte de 175 patients (2016) (1)
- Coxopathie destructrice goutteuse (1997) (1)
- AB0332 IMMUNOSUPPRESSIVE AND IMMONOMODULATING AGENTS IN RHEUMATOID ARTHRITIS: A SYSTEMATIC REVIEW OF CLINICAL TRIALS AND THEIR CURRENT DEVELOPMENT STAGE (2020) (1)
- L' évaluation structurale dans la prise en charge de personnes souffrant de polyarthrite rhumatoïde établissement de recommandations pour la pratique clinique à partir de données de la littérature et d'opinions d'experts (rencontres d'experts en rhumatologie) (2004) (1)
- Les proliférations lymphoïdes sous méthotrexate prescrit à faible dose dans la polyarthrite rhumatoïde (1998) (1)
- POS0095 DEVELOPPING A SCORE TO PREDICT PRECLINICAL INTERSTITIAL LUNG DISEASE IN PATIENTS WITH RHEUMATOID ARTHRITIS – A CROSS-SECTIONAL STUDY FROM THE ESPOIR COHORT (2021) (1)
- [What do we know about the cardiovascular toxicity of the NSAIDs?]. (2006) (1)
- La réticulohistiocytose multicentrique : une affection auto-immune systémique ? À propos d’une forme associée à une polyarthrite rhumatoïde érosive et un syndrome de Sjögren systémique (2010) (1)
- SAT0209 Idiopathic Inflammatory Myopathies: Evaluation of Skeletal Muscle Glucose Metabolism by PET-CT 18F-FDG (2016) (1)
- Muscle disorders111. The impact of fatigue in patients with idiopathic inflammatory myopathy: a mixed method study (2012) (1)
- Naissance et développement de l’immunothérapie ciblée : La révolution des biomédicaments (2007) (1)
- Infections ostéoarticulaires à Streptococcus pneumoniae chez l'adulte immunocompétent : a propos de deux observations (2006) (1)
- Les traitements non médicamenteux dans la prise en charge de personnes atteintes de polyarthrite rhumatoïde récente : établissement de recommandations pour la pratique clinique à partir de données de la littérature et d'opinions d'experts (2005) (1)
- SAT0379 Is Fatigue Immune-Mediated in Primary SjÖgren's Syndrome? Data from the Prospective Assess Cohort (2015) (1)
- Favorable Effect of Very Early Disease-Modifying Antirheumatic Drug Treatment on Radiographic Progression in Early Inflammatory Arthritis Data From theet Suivi des Polyarthrites Indiff´´ R´ (Study and Followup of Early Undifferentiated Polyarthritis) (2011) (1)
- Onycho-périostite psoriasique récidivante déclenchée par l'hydroxychloroquine (1995) (1)
- A centrofacial B lymphoma in a rheumatoid arthritis patient. (2007) (1)
- Polyarthralgies inflammatoires et troubles digestifs révélant une amylose AL systémique compliquant un lymphome de type MALT digestif, suivie pendant 10 ans (2017) (1)
- Ostéome ostéoïde du coude : un mode de révélation trompeur (2013) (1)
- Étude descriptive de la cohorte franco–allemande LBBR de patients ayant un lupus erythémateux systémique (2017) (1)
- Dermatomyositis flare on imiquimod therapy highlights a crucial role of aberrant TLR7 signalling (2016) (1)
- Basic (PS01–PS58) (2012) (1)
- OP0184 Clinical Spectrum and Therapeutic Management of Systemic Lupus Erythematosus-Associated Macrophage Activation Syndrome. Data from A French Nationwide Study of 81 Episodes in 67 Adult Patients (2016) (1)
- Le lymphocyte B : cible thérapeutique privilégiée dans les maladies auto-immunes (2007) (1)
- Increase in methotrexate dose in patients with rheumatoid arthritis who have an inadequate response to infliximab (2005) (1)
- Arthrite au cours d’une spondylarthropathie révélatrice d’un ostéome ostéoïde (2008) (1)
- Caractéristiques clinicobiologiques et radiologiques du rhupus : résultats d’une cohorte de 28 patients (2010) (1)
- Efficacité et tolérance de l'etanercept dans le rhupus: étude prospective de huit patients (2006) (1)
- Caractéristiques des patients français atteints de pneumopathie interstitielle diffuse au cours de la sclérodermie systémique (PID-ScS) à partir de la base de données European Scleroderma Trials and Research (EUSTAR) (2020) (1)
- Sicret-syndrome : un diagnostic différentiel des vascularites et du syndrome des antiphospholipides (1999) (1)
- [Cartilaginous tumors and other cutaneous lesions]. (1996) (1)
- Les bénéfices thérapeutiques d’un traitement systémique du rhumatisme psoriasique ? L’exemple du golimumab dans le rhumatisme psoriasique (2011) (1)
- Bisphosphonates in rheumatoid arthritis (osteoporosis excluded). (1999) (1)
- THU0446 Trabecular bone texture parameters are correlated with magnetic resonance imaging (MRI) bone edema at hand and wrist in active rheumatoid arthritis (RA) (2013) (1)
- Iconography : OSTÉOPATHIES MÉDICAMENTEUSES (2008) (1)
- [Diagnostic criteria for Sjögren's syndrome]. (2012) (1)
- Septicémie à Yersinia pseudotuberculosis traitée par fluoroquinolones (1991) (1)
- Acute renal failure in systemic sclerosis revealing Goodpasture syndrome: “All that glitters is not scleroderma renal crisis” (2019) (1)
- Taux de rétention de l’adalimumab, de l’étanercept et de l’infliximab en 1re ou 2e ligne de biothérapie chez les patients atteints de polyarthrite rhumatoïde en pratique courante (2014) (1)
- Mise à jour des recommandations de la Société française de rhumatologie pour l'utilisation des agents anti-TNF alpha chez les personnes souffrant de polyarthrite rhumatoïde (PR) (2007) (1)
- Biomédicaments et petites molécules immunomodulatrices et immunosuppressives (2012) (1)
- AB0742 Hand x-ray lesions are frequent in antisynthetase syndrome patients with arthralgia and increase with the radiographic follow-up, whatever the extra-articular features and the serotype of antisynthetase syndrome (2018) (1)
- Hypertension artérielle pulmonaire au cours du lupus systémique (2012) (1)
- [Alpha-2b interferon and hypothyroidism]. (1992) (1)
- Anti-pseudo PCNA auto antibodies: Clinical and biological correlates in a single center cohort of 48 patients (2013) (1)
- FRI0246 Serious infusion-related reactions after rituximab in patients with rheumatoid arthritis: data from the autoimmunity and rituximab registry (2013) (1)
- Rôle phénotypique des anticorps anti-Ro52 (TRIM21) dans le syndrome des anti-synthétases (étude RoSAS) : marqueur prédictif de sévérité ? (2017) (1)
- SAT0152 Safety of Surgery in Patients Treated with Tocilizumab for Rheumatoid Arthritis: Data from The Regate Registry (2016) (1)
- OP0062 Assessment of biotherapies' efficacy in blau syndrome: data from an international retrospective cohort of 23 cases (2017) (1)
- FRI0398 Inflammatory myopathies with camptocormia or dropped head syndrome are associated scleromyositis with late onset and delayed diagnosis (2017) (1)
- Intérêt du dosage de la C-réactive protéine intra-articulaire dans le diagnostic de l’infection périprothétique du genou. Une étude préliminaire (2014) (1)
- O5 Worldwide trends in all-cause mortality of auto-immune systemic diseases between 2001 and 2014 (2020) (1)
- La polyarthrite rhumatoïde: comment l'expliquer? Maladie auto-immune ou maladie hyperinflammatoire ? (2011) (1)
- Prévalence du COVID-19 et des poussées inflammatoires chez les patients atteints de maladie auto-immunes systémiques rares : enquête systématique téléphonique et sérologique dans un centre national de référence (2020) (1)
- The gap between practice and guidelines in the choice of the first-line DMARD in early rheumatoid arthritis ? Results from the ESPOIR cohort (2009) (1)
- [Diagnostic and prognostic value of magnetic resonance imaging in multiple myeloma: the clinician's point of view]. (1998) (1)
- Intérêt diagnostique et nosologique des autoanticorps dans les myopathies inflammatoires (2006) (0)
- Caractérisation des profils de fatigue au sein d’une large cohorte internationale de patients atteints de lupus systémique (2020) (0)
- L'immunité innée : la face cachée de l'immunopathologie sous les feux des projecteurs : Première partie: immunité innée et environnement microbien (2006) (0)
- Trained immunity et pathologies auto-immunes : Ève fautive avant Adam ? (2019) (0)
- Efficacité de l'anakinra dans une goutte réfractaire corticodépendante (2007) (0)
- ACTUALITÉS SUR LA POLYARTHRITE RHUMATOÏDE (2009) (0)
- Suivi clinicobiologique des grossesses lupiques (2010) (0)
- Impact de l’uricémie sur le rhumatisme psoriasique : étude cas-témoins d’une cohorte de 242 patients (2020) (0)
- Biofármacos y terapias dirigidas mediante pequeñas moléculas inmunosupresoras (2020) (0)
- Infliximab ou rituximab pour le traitement des maladies de Wegener réfractaires : une étude prospective multicentrique sur 17 patients (2010) (0)
- Le traitement du lupus érythémateux systémique en 2006 (2006) (0)
- Fractures de contrainte du calcanéum chez le sujet âgé (1991) (0)
- Association entre un polymorphisme du gène de l'endogline et l'hypertension artérielle pulmonaire de la sclérodermie systémique (2006) (0)
- Incidence des cancers des patients ayant une polyarthrite rhumatoïde et un antécédent de cancer traités par rituximab ou abatacept (2016) (0)
- Dénigrement excessif de l’examen clinique en rhumatologie : faut-il abandonner le concept de gold-standard, et user de l’intelligence artificielle? (2022) (0)
- Les examens immunologiques en rhumatologie (2007) (0)
- La surexpression de la tyrosine kinase de Bruton (BTK) est un facteur de risque indépendant de lymphome compliquant le syndrome de Sjögren primaire : données de 346 patients de la cohorte de la SFR ASSESS (2022) (0)
- 18 – Quel est le risque de cancer et de lymphome dans le lupus érythémateux systémique ? (2013) (0)
- L’auto-évaluation de la maladie dans la polyarthrite rhumatoïde (PR) par l’auto-DAS28 est-elle acceptable au long cours ? Suivi à 3 ans d’un programme réalisé par des infirmiers (COMEDRA) chez 771 patients atteints de PR établie (2016) (0)
- Aspects médico-économiques réglementaires et sociaux (2001) (0)
- Pancréatite aiguë au cours de la polyarthrite rhumatoïde : quelles étiologies ? (2015) (0)
- Prise en charge pratique des patients sous inhibiteurs de Janus Kinases (JAKi). Fiches pratiques élaborées par le Club Rhumatismes et Inflammation (CRI), Association reconnue par la Société Française de Rhumatologie (SFR) (2018) (0)
- Arbres décisionnels de l'article : Biomédicaments et petites molécules immunomodulatrices et immunosuppressives (2012) (0)
- Fissure osseuse du scaphoîde tarsien au cours d'une algodystrophie : intérêt diagnostique de l'IRM (1994) (0)
- Les maladies auto-immunes: toujours des maladies “vedettes” (2003) (0)
- Centre de référence, centre de compétences: quels rôles en rhumatologie? (2010) (0)
- Pathogénie des ruptures de la coiffe des rotateurs. Discussion (1996) (0)
- Tolérance des retraitements multiples par rituximab : données à long terme du registre AIR (2016) (0)
- Journées dermatologiques 2007 Quoi de neuf ? Quoi de neuf en médecine en 2007 ? (2008) (0)
- Efficacité et tolérance du tocilizumab en pratique quotidienne chez 26 patients atteints de polyarthrite rhumatoïde (2010) (0)
- PTPN22 n'est pas un facteur génétique de susceptibilité de la sclérodermie systémique chez les malades caucasiens français (2007) (0)
- Un cas de fistule artérioveineuse durale intracrânienne à drainage veineux péri-médullaire (1999) (0)
- La collaboration dermatologue–rhumatologue dans les maladies inflammatoires et systémiques (2011) (0)
- Excès de variants rares délétères au sein de gènes appartenant à la voir JAK-STAT chez des patients atteints de pneumopathie interstitielle diffuse associée à la polyarthrite rhumatoïde (2022) (0)
- Quel est le rôle des micro-organismes dans la pathogénie des arthrites réactionnelles et des autres spondylarthropathies ? (1998) (0)
- Efficacité et tolérance d'Abatacept à long terme (3 ans) chez les patients ayant une polyarthrite rhumatoïde – Etudes AIM et ATTAIN (2007) (0)
- Les réseaux en rhumatologie : aspects pratiques (2003) (0)
- L'abatacept dans la polyarthrite rhumatoïde en pratique courante, hors essais cliniques (2009) (0)
- P109 Rhumatologie L'arthrite juvenile idiopathique en alsace. Enquete epidemiologique retrospective (2003) (0)
- Les immunomodulateurs dans les maladies systémiques en réanimation médicale : aspects pratiques et perspectives thérapeutiques (2005) (0)
- Complications post-chirurgicales chez des patients traités par Tocilizumab pour leur polyarthrite rhumatoïde : Données extraites du registre REGATE (2016) (0)
- Les vascularites: classification, aspects cliniques, diagnostiques et thérapeutiques (2002) (0)
- Incidence des effets paradoxaux survenant chez les patients ayant une polyarthrite rhumatoïde sous tocilizumab : données du registre français REGATE (2016) (0)
- [Benign monoclonal gammopathies]. (1993) (0)
- Conférence d’actualité: Conduite à tenir devant une suspicion de myosite (2018) (0)
- Caractéristiques cliniques et immunologiques du syndrome des antiphospholipides chez le sujet d’âge mûr : une étude rétrospective nationale multicentrique (2018) (0)
- Les affections inhabituelles de l'épaule (2001) (0)
- Syndrome de Sjögren primitif : critères diagnostiques et de suivi (2010) (0)
- Efficacité de l’anakinra dans une goutte réfractaire corticodépendante (2008) (0)
- Une ascite de la femme jeune (2000) (0)
- Le Relapsing Polychondritis Damage Index (RPDAM) : développement d’un score lésionnel au cours de la polychondrite atrophiante (2020) (0)
- Immunomodulateurs dans les maladies inflammatoires (2012) (0)
- Association entre les gènes IL-2RA et IL-2RB et l’état érosif chez les patients atteints de polyarthrite rhumatoïde précoce (cohortes ESPOIR et RMP) ☆ (2014) (0)
- Effet de la vaccination anti-SARS-CoV-2 sur les symptômes prolongés post-Covid : résultat de l’enquête nationale VAXILONG (2021) (0)
- Maladies auto-immunes et maladies auto-inflammatoires : quel lien ? (2007) (0)
- Epidémiologie des lésions de la coiffe des rotateurs. Discussion (1996) (0)
- Stratégies d’arrêt ou de réduction des biomédicaments dans la polyarthrite rhumatoïde en rémission (2017) (0)
- Prévalence de la pneumopathie interstitielle diffuse associée à la polyathrite rhumatoïde dans la cohorte Espoir et intérêt du génotypage de rs35705950 (2020) (0)
- Une arthrite au cours d'une spondylarthropathie … révélatrice d'un ostéome osteoïde (2007) (0)
- Données de tolérance à long terme après traitement et retraitement par RTX dans la polyarthrite rhumatoïde (2007) (0)
- Les manifestations rhumatologiques des endocardites bactériennes (1988) (0)
- Prévalence et facteurs de risque d’ostéonécrose aseptique chez 807 greffés rénaux (2016) (0)
- Les traitements du lupus systémique : retour vers le futur (2019) (0)
- Implication des systèmes nerveux et neuroendocrine dans la polyarthrite rhumatoïde (2003) (0)
- Au cours du syndrome des antisynthétases, les anticorps anti-peptides citrullinés sont un marqueur d’atteinte articulaire sévère (2012) (0)
- Efficacité des antagonistes du TNFalpha dans la maladie de Takayasu (2011) (0)
- Les proliférations lymphoïdes sous méthotrexate à faible dose dans la polyarthrite rhumatoïde (1998) (0)
- LES EXAMENS SEROLOGIQUES MICROBIOLOGIQUES DANS LE DIAGNOSTIC DES ARTHROPATHIES INFLAMMATOIRES : QUELLES SEROLOGIES ? COMMENT LES INTERPRETER ? (1999) (0)
- Représentation sociale et vécue de l’incertitude chez les patients atteints de spondyloarthrite et de polyarthrite rhumatoïde : étude qualitative (2021) (0)
- Coordination régionale et suivi prospectif du traitement prophylactique et curatif de 301 patients traités par anticorps monoclonaux anti-SARS-CoV-2 (2022) (0)
- Tolérance des anti-TNF chez des patients atteints de polyarthrite rhumatoïde précédemment traités par rituximab (2006) (0)
- Les autoanticorps : comment les rechercher, et quelle est leur valeur diagnostique ? (2003) (0)
- CIFPSS 2021 : un congrès singulier (2021) (0)
- La tolérance à long terme du rituximab, de l’abatacept et du tocilizumab est similaire d’après les données des registres AIR, ORA et REGATE de la SFR (2016) (0)
- 14 – Comment dépister et prendre en charge une ostéonécrose au cours du lupus érythémateux ? (2013) (0)
- Efficacité et sécurité de l’infliximab princeps pour traiter des patients atteints de maladie de Takayasu dans la cadre de la RTU (Recommandation Temporaire d’Utilisation) en France (2017) (0)
- Apparition de vitiligo sous biothérapie : une série de 12 cas (2014) (0)
- Mise au point Les immunomodulateurs dans les maladies systémiques en réanimation médicale : aspects pratiques et perspectives thérapeutiques Immunosuppressive agents in systemic diseases : a critical care perspective (2005) (0)
- Difficultés et vécu de la pandémie Covid-19 des patients atteints de lupus systémique : résultats de l’enquête nationale EPICURE (2021) (0)
- Prévention des ulcères digitaux de la sclérodermie systémique par le bosentan. Étude française rétrospective de 89 patients traités depuis 2007 (2011) (0)
- Aspects cliniques, diagnostiques et thérapeutiques : Le syndrome des antiphospholipides (2002) (0)
- Évolution des biomarqueurs associés au risque cardiovasculaire sous anti-TNF versus autres biothérapies dans la polyarthrite rhumatoïde: étude ancillaire de l’essai ROC (2016) (0)
- Facteurs pronostiques des agranulocytoses médicamenteuses :étude d'une cohorte de 91 patients (2001) (0)
- Rheumatoid arthritis and other inflammatory joint diseases (human studies) (PP-036) (2010) (0)
- Fond génétique partagé entre la pneumopathie interstitielle diffuse associée à la polyarthrite rhumatoïde et la fibrose pulmonaire idiopathique (2016) (0)
- De curieuses fractures de côtes spontanées chez un homme jeune (2004) (0)
- Biomédicaments « cibles » dans les maladies auto-immunes et inflammatoires systémiques (2016) (0)
- P87 - Infliximab et acrodermatite continue de Hallopeau : une réussite en pointillés… (2005) (0)
- La prise en charge de la polyarthrite rhumatoïde en 2011 : stratégie et utilité des nouveaux biomédicaments (2011) (0)
- Étude rétrospective sur l'ostéonécrose de mâchoire sous aminobisphosphonates intraveineux dans le service de rhumatologie (2007) (0)
- Rituximab au cours de la polyarthrite rhumatoïde et des maladies auto-immunes systémiques (2011) (0)
- Utilisation du rituximab dans la leucémie à grands lymphocytes à grains associée à la polyarthrite rhumatoïde: étude rétrospective multicentrique (2020) (0)
- Le lupus systémique : quelle actualité ? (2009) (0)
- Caractérisation des mécanismes qui sous-tendent les lésions des fibres périfasciculaires au cours de la dermatomyosite : une approche combinant l’analyse transcriptomique et topographique (2020) (0)
- Polymorphismes +49A/G et CT60 de CTLA-4 et prédisposition génétique au syndrome de Sjögren primitif (2006) (0)
- Un tiers des patients atteints de polyarthrite rhumatoïde (PR) établie sont correctement vaccinés contre la grippe et le pneumocoque et cette proportion augmente : évaluation longitudinale sur 3 ans des 769 patients de l’étude COMEDRA (2016) (0)
- La formation à la recherche : un enjeu majeur pour les médecins de demain (2018) (0)
- Évaluation de l’efficacité des biothérapies dans le syndrome de Blau : étude sur une cohorte internationale de 23 cas (2016) (0)
- Impact de l’éducation thérapeutique du patient sur les compétences de sécurité des patients sous biothérapie pour un rhumatisme inflammatoire chronique (2019) (0)
- Maladies auto-immunes et systémiques (2002) (0)
- Nouveau mécanisme d’action des inhibiteurs de la voie JAK/STAT : l’inhibition de la différenciation et de la fonction des lymphocytes T folliculaires auxiliaires (2016) (0)
- Acceptation par les rhumatologues des recommandations pour la prise en charge en pratique courante des personnes atteintes de polyarthrite rhumatoïde (2005) (0)
- Les glomérulopathies membrano-proliférative : une manifestation du POEMS syndrome ? à propos d'un cas (2006) (0)
- Aspects réglementaires et médico-économiques (2002) (0)
- ARTHROPATHIES DEGENERATIVES , CHONDROCALCINOSE ET HYPERSIDEREMIE CHEZ UN HOMME DE 72 ANS : QUEL EST VOTRE DIAGNOSTIC ? (1999) (0)
- Les auto-anticorps de la polyarthrite rhumatoïde : Intérêt diagnostique, pronostique et évolutif (1998) (0)
- A1.71 Reduced dicer expression correlates with rheumatoid arthritis (2014) (0)
- Évolution de l’immunité cellulaire et humorale anti-SARS-CoV-2 après 3 doses de vaccins chez des patients traités par rituximab (2021) (0)
- Théorie de la discontinuité : un rôle de l’infection à SARS-CoV-2 dans le développement de l’auto-immunité ? (2022) (0)
- Quelle est la place de 1' étanercept dans le traitement d'une polyarthrite rhumatoïde débutante et/ou non préalablement traitée par le méthotrexate? (2004) (0)
- Caractéristiques urodynamiques des troubles vésicosphinctériens du syndrome fibromyalgique (1997) (0)
- Les réseaux en rhumatologie : principes généraux (2003) (0)
- Pneumomédiastin au cours des myopathies inflammatoires. Etude pronostique de 11 cas et analyse de la littérature (2007) (0)
- Des lésions cutanées atypiques (2016) (0)
- Comparaison d’un traitement d’entretien prolongé par rituximab contre un traitement d’entretien de durée conventionnelle dans les vascularites associées aux ANCA. Étude prospective, multicentrique, contrôlée, randomisée contre placebo (2019) (0)
- Biothérapies dans la maladie de Takayasu : étude française rétrospective (2014) (0)
- Des nouvelles des rhumatismes inflammatoires et des maladies systémiques : Organisation des soins et aspects réglementaires (2003) (0)
- Expression de BAFF par les synoviocytes fibroblast-like en réponse aux microparticles (2007) (0)
- Incertitude en rhumatologie : étude qualitative (2020) (0)
- THU0443 Anakinra Might Cause Acute Hepatitis in Patients with Systemic Onset Juvenile Idiopathic Arthritis and Adult Onset Still Disease (2013) (0)
- Métastases osseuses liquidiennes multiples (2010) (0)
- IRM du muscle : tout ce qui brille n’est pas nécessairement une myosite ☆ (2015) (0)
- Incertitude diagnostique et stratégie décisionnelle en clinique (2017) (0)
- La borréliose de Lyme chez l'enfant : aspects cliniques et thérapeutiques (2001) (0)
- Maladie de Lyme : actualités (2011) (0)
- Connaissance de la maladie par le patient : étude multicentrique française dans la spondylarthrite ankylosante (2004) (0)
- Faut-il vacciner un sujet atteint de polyarthrite rhumatoïde, et comment procéder ? Le rhumatologue peut mieux faire (2008) (0)
- Le dépistage et la prévention des comorbidités dans la polyarthrite rhumatoïde (PR) après un programme d’information par infirmier : suivi à 3 ans de 769 patients atteints de PR établie de l’étude COMEDRA (2016) (0)
- Quoi de neuf en médecine en 2007 (2007) (0)
- Étude rétrospective multicentrique des caractéristiques cliniques et biologiques de patients porteurs d'anticorps anti-PMScl (2003) (0)
- Manifestations rares d'allure auto-immuneaprès al logreffe de moelle osseuse: À propos de 9 patients (2003) (0)
- La borréliose européenne : une affection fascinante… et encore mal connue (2004) (0)
- Les sites web de partage de vidéos peuvent-ils constituer une aide à la formation au geste d’infiltration de l’espace sous-acromial ? (2016) (0)
- Prédiction de la réponse aux traitements de fond antirhumatismaux (DMARD) dans la polyarthrite rhumatoïde (2010) (0)
- L'hyperlaxite articulaire (1991) (0)
- Interféron dans le traitement du myélome: effets indésirables, en particulier thyroïdiens (1993) (0)
- Tolérance des perfusions d'abatacept chez les patients atteints de polyarthrite rhumatoïde. Synthèse des résultats de 5 études (2006) (0)
- Facteurs pronostiques des lésions radiographiques à 10 ans dans la polyarthrite rhumatoïde débutante (PR) (2006) (0)
- L’hypertension artérielle pulmonaire lupique : deux nouveaux cas (2010) (0)
- Les vaccinations dans les rhumatismes inflammatoires chroniques de l’adulte : le calendrier vaccinal et les recommandations en cas de traitement de fond classique et biologique (2016) (0)
- Prise en charge d'une grossesse lupique: suivi standardisé de 46 grossesses lupiques (2006) (0)
- Anti-TNFα et manifestations systémiques des spondylarthropathies (2008) (0)
- Risque cardiovasculaire et polyarthrite rhumatoïde : établissement de recommandations pour la pratique clinique à partir de données de la littérature et d'opinions d'experts (2005) (0)
- Microbiotes tissulaires: un ‘Soi-secondaire’, première cible des maladies auto-immunes? (2022) (0)
- Efficacité à long terme de l'abatacept chez des patients atteints de polyarthrite rhumatoïde (PR). Résultats à deux ans de l'étude AIM (2006) (0)
- Incertitude médicale en rhumatologie : étude qualitative (2022) (0)
- Morphées généralisées et polyarthrite chronique (1991) (0)
- Polyarthrite sèche juvénile : nouvelle maladie ou tableau atypique d'un rhumatisme chronique connu ? (2006) (0)
- Les maladies auto-immunes : Des avancées fondamentales et pratiques 1ère partie : Les progrès de l'immunopathologie (2006) (0)
- Inertie clinique dans le rhumatisme psoriasique : analyse prospective (2022) (0)
- Recommandations francophones, internationales et multidisciplinaires d’experts pour l’utilisation de biomédicaments dans le lupus érythémateux systémique: le groupe de travail du CRI-IMIDIATE (2016) (0)
- Régression d’une ostéosclérose associée à l’hépatite C (HCAO) après traitement antiviral (2011) (0)
- Enquête sur l’inertie thérapeutique dans le rhumatisme psoriasique (2022) (0)
- Quel type d'imagerie diagnostique et préthérapeutique (médicale ou chirurgicale) faut-il réaliser devant une épaule douloureuse avec arthrose glénohumérale ? Discussion (1997) (0)
- Tolérance et efficacité des thérapies ciblées prescrites dans des indications hors AMM au cours des maladies auto-immunes systémiques réfractaires : données des 100 premiers patients inclus dans le registre TATA (TArgeted Therapy in Auto-immune Diseases) (2021) (0)
- Iconography : Inflammatory myopathies: A new landscape (2017) (0)
- Agranulocytose médicamenteuse : étude rétrospective monocentrique de 98 cas (2009) (0)
- Tolérance de l'abatacept dans le traitement de la polyarthrite rhumatoïde (2009) (0)
- [Recombinant proteins or monoclonal antibodies: comparative properties and interest in rheumatoid arthritis]. (2009) (0)
- Iconography : Survival in the rheumatoid synovium (2011) (0)
- Signification clinique des anticorps anti-ribosomes anti-P (P0, P1, P2) et anti-non-P (1998) (0)
- FRI0381 During antisynthetase syndrome, anti-citrullinated peptides are a marker of severe joint disease (2013) (0)
- SAT0226 Cigarette smoking in pss: association with earlier onset, male sex and serum baff increase in the assess cohort (2013) (0)
- SUSTAINED IMPROVEMENTS IN DAS28 AND PATIENT-REPORTED OUTCOMES WITH ABATACEPT IN THE LONG-TERM EXTENSION OF THE ATTAIN (ABATACEPT TRIAL IN TREATMENT OF ANTI-TNF INADEQUATE RESPONDERS) TRIAL: 159 (2006) (0)
- [A fool's reform: the imbroglio of « intermediate professions »]. (2021) (0)
- FRI0235 Incidence of Paradoxical Reactions in Patients with Rheumatoid Arthritis during Tocilizumab Therapy: Data from The French Registry Regate (2016) (0)
- [Drug-induced agranulocytosis in rheumatology. A retrospective study of 12 cases]. (2007) (0)
- THU0106 Identification of Markers Associated with The Occurrence of Interstitial Lung Disease in Rheumatoid Arthritis Patients (2016) (0)
- AB0568 Biologics in Takayasu Arteritis: Preliminary Data from the French Registry (2014) (0)
- Un syndrome arthro-dermato-pulmonaire associé aux anticorps anti-MDA5 (2014) (0)
- Letter to the Editor Perioperative Management of Patients with Rheumatoid Arthritis Treated with TNF- Blocking Agents (2007) (0)
- Abstract 4383: Incidence of Pulmonary Arterial Hypertension in Patients with Systemic Sclerosis: A 3-Year Longitudinal Study (2008) (0)
- Revisiting the Association Between Systemic Lupus Erythematosus and Gout. (2019) (0)
- In antisynthetase syndrome, amyloidosis is rare and might not be related to the disease (2012) (0)
- [Periodic certification of physicians for personalized professional development]. (2019) (0)
- Une cause rare de cervicalgies : la maladie de Kikuchi-Fujimoto (1997) (0)
- THU0404 Recommendations from an International Task Force for the Use of Biologics in Systemic Lupus Erythematous (2015) (0)
- Rheumatoid Fibroblast-Like Synoviocytes by Lipopolysaccharide-Activated miR-346-Related Regulation of IL-18 Release Bruton's Tyrosine Kinase Is Involved in (2009) (0)
- Epilepsy and Paget's disease. (1995) (0)
- Affections auto-inflammatoires : critères de diagnostic et de classification (2010) (0)
- [Joint pain and effusions. Recent arthritic progression]. (2004) (0)
- FRI0400 Efficacy of anakinra in calcium pyrophosphate crystal arthritis (2013) (0)
- SAT0210 Hierarchical Cluster Study of Patients with Anti-KU Antibodies Identifies Two Phenotypical Subgroups with Distinct Prognosis Recognized by Anti-DNA Status (2016) (0)
- [Reform of medical studies: an unprecedented project]. (2019) (0)
- AB0173 Metabolomics in Primary SjÖgren's Syndrome: Data from the Assess Cohort (2015) (0)
- trial and ESPOIR cohort rheumatoid arthritis : data from the GUEPARD activeroutine care in patients with recent-onset Disease activity score-driven therapy versus (2011) (0)
- [Demography of health professions: history and perspective]. (2020) (0)
- CTLA-4 + 49 A / G and CT 60 gene polymorphisms in primary Sjögren syndrome (2015) (0)
- OP0218 Elevated Serum BAFF is Associated with an Increased Risk of Developing A New Systemic Complication: Data from the Prospective ASSESS Cohort (2014) (0)
- FRI0286 Rank-l is expressed by salivary gland epithelial cells in primary sjogren’s syndrome: a novel actor in ectopic lymphoid structure neogenesis (2018) (0)
- SAT0044 Five-Year Favourable Outcome of Patients with Early Rheumatoid Arthritis in the 2000S: Data from the Espoir Cohort (2013) (0)
- [Immunosuppressive treatment: administration, adverse effect, prophylactic measures]. (2006) (0)
- Recommandations de la Société française de rhumatologie pour l'utilisation des agents anti-TNFα chez les personnes souffrant de polyarthrite rhumatoïde Recommendations of the French Society for Rheumatology Regarding TNFα Antagonist Therapy in Patients with Rheumatoid Arthritis ◊ (2007) (0)
- POS1190 EXPECTATIONS AND POTENTIAL CONCERNS OF PATIENTS WITH AUTOIMMUNE AND RHEUMATIC DISEASES REGARDING VACCINATION AGAINST SARS-CoV-2 (COVID-19): THE WORLDWIDE ONLINE VAXICOV STUDY (2021) (0)
- Bruton's tyrosine kinase and microRNA miR-346 regulate IL-18 release by LPS-activated rheumatoid fibroblast-like synoviocytes (2009) (0)
- [Research training: a major challenge for future MDs]. (2018) (0)
- AB0444 Impact of Gender on the Response and the Tolerance to Treatment with Abatacept in RA Patients: Results from the “Orencia and Rheumatoid Arthritis” Registry (2015) (0)
- Une cause rare de cervicalgies : Le syndrome de Kikuchi-Fujimoto (1996) (0)
- SAT0454 In primary sjÖgren’s syndrome blood cd180-negative b cells are increased in patients with high systemic disease activity (2018) (0)
- [A memory of Indo-China]. (2006) (0)
- THU0064 Clinical signification of anti-ku antibody (2001) (0)
- THU0597 Comparaison of Self Assessment of Disease Activity To Das28 in Rheumatoid Arthritis: Data from The Randomized “Roc” Trial (2016) (0)
- Assessment of clinical risk factors of osteoporosis, bone mineral density and fracture prevalence in systemic sclerosis (2011) (0)
- Rheumatoid arthritis - treatment 180. Utility of Body Weight Classified Low-Dose Leflunomide in Japanese Rheumatoid Arthritis (2011) (0)
- [What do we know about the cardiovascular toxicity of the NSAIDs?]. (2006) (0)
- AB0652 Granulomatosis and Inflammatory Myopathy: Clinical Serological Pathological Features and Prognosis (2016) (0)
- AB1049 CLINICAL SPECTRUM AND THERAPEUTIC MANAGEMENT OF AUTO-IMMUNE MYELOFIBROSIS: A NATION-WIDE STUDY OF 30 CASES (2020) (0)
- AB0779 Eosinophilic myositis and rheumatoid arthritis as first manifestation in a patient carrying myotonic dystrophy type 2 (CCTG)n expenssion of ZNF9 gene (2013) (0)
- 33 - Post-Infectious Arthritis: Reactive Arthritis or Slow Infectious Arthritis? (2004) (0)
- [Peroperative anaphylactoid reaction in systemic mastocytosis]. (1994) (0)
- Reactive arthritis or chronic infectious arthritis? (2002) (0)
- La corticothérapie locale dans le traitement de la pathologie de la coiffe des rotateurs (tendinopathies calcifiantes et capsulites rétractiles exclues). Discussion (1996) (0)
- Skeletal fluorosis: An unusual metabolic bone complication in HPN patients (2003) (0)
- [Spontaneous fracture of the calcaneus in the aged subject without any fluoride therapy]. (1989) (0)
- THU0322 Altered Quality of Life Is Mainly Associated with Patient Reported Outcomes in Primary Sjögren's Syndrome Patients: Data from A Large Therapeutic Trial (2016) (0)
- Biosimilar N 1 ¶ N 2 ¶ in fl iximab for the management of rheumatoid arthritis in France : what are the expected savings ? (2016) (0)
- Corticosteroid Sparing Effect of Non-TNF Targeted Biologics, Rituximab, Abatacept and Tocilizumab in Common Practice: Data from 3183 Patients Enrolled in the French Society of Rheumatology Registries (2017) (0)
- Evaluation of Liver Gene Therapy by Lentiviral Vectors in a Dog Model of Hemophilia B (2012) (0)
- [Atypical skin lesions]. (2016) (0)
- FRI0434 Patients with inflammatory myopathies admitted in icu are characterised by recent onset and untreated active disease as well as older age and high comorbidities (2018) (0)
- THU0107 CCL19, a chemokine involved in B-cell trafficking, is related to the decrease of blood memory B-cells and predicts the clinical response to rituximab in rheumatoid arthritis: Results from the smart study (2013) (0)
- OP0181 CURRENT FAVOURABLE 10-YEAR OUTCOME OF PATIENTS WITH EARLY RHEUMATOID ARTHRITIS: DATA FROM THE ESPOIR COHORT (2021) (0)
- [European tick-bite disease: a fascinating disease...but not much known about]. (2004) (0)
- AB0780 Frequency and characteristics of cancer associated myositis in a cohort of 20 patients with anti-jo-1 positive myositis (2013) (0)
- SAT0175 Response to biologic treatment improves sexual health assessed by the qualisex score in ra (2018) (0)
- [Discontinuation or tapering strategies of biologics in rheumatoid arthritis in remission]. (2017) (0)
- FRI0249 IN MYOSITIS PATIENTS, SJÖGREN’S SYNDROME IS ASSOCIATED WITH INCLUSION BODY MYOSITIS AND WITH ANTI-CN1A ANTIBODIES INDEPENDENTLY OF THE MYOSITIS SUBTYPE (2020) (0)
- SAT0059 Criteria for Choice by Clincians of The Therapeutic Strategy in Patients with Insufficient Response To A First Anti-TNF: Data from The Randomized “Roc” Criteria (2016) (0)
- THU0152 Who are the patients with rheumatoid arthritis (RA) who are getting comorbidity screening procedures in accordance with guidelines? a study of 769 established ra patients (2017) (0)
- THU0177 Prognostic factors of remission in early rheumatoid arthritis (ra). a multiparameter prospective study (2001) (0)
- SLE and other connective tissue diseases (animal models) (PP-017) (2010) (0)
- SAT0208 Inflammatory Myopathies Associated with Sjögren's Syndrome Do Not Differ from Those without Sjögren's Syndrome Aside from Older Age at Diagnosis and Less Frequent Normal Muscle Biopsy (2016) (0)
- Rheumatoid arthritis and other inflammatory joint diseases (human studies) (WS-036) Chairpersons: Tsutomu Takeuchi, Nobuyuki Miyasaka (2010) (0)
- NLRP3- and AIM2-autonomy in a mouse model of MSU crystal-induced acute inflammation in vivo highlights imiquimod-dependent targeting of Il-1β expression as relevant therapy for gout patients (2019) (0)
- [Intra-articular osteoid osteoma in the left elbow]. (2013) (0)
- OP0243 AN APPROACH COMBINING TRANSCRIPTOMIC AND TOPOGRAPHIC ANALYSIS REVEALS A POTENTIAL ROLE OF PROTEASOME AND AUTOPHAGY DEREGULATION IN THE PATHOPHYSIOLOGY OF DERMATOMYOSITIS (2021) (0)
- Absence de progression radiographique à 2 ans dans l'étude AIM (Abatacept in Rheumatoid arthritis patients with Inadequate response to MTX) (2006) (0)
- Chordome lombaire post-traumatique (1993) (0)
- [Arthritis revealing an osteoid osteoma in a patient with spondylarthropathy]. (2008) (0)
- Practical management of patients on Janus kinase inhibitor (JAKi) therapy - the CRI fact sheets. (2019) (0)
- FRI0337 INCIDENCE AND PREVALENCE OF MYOSITIS ASSESSED BY MULTI-SOURCES CAPTURE-RECAPTURE METHODOLOGY (2019) (0)
- AB0450 Impact of therapeutic patient education on safety skills and infectious events of patients treated by biological dmards in rheumatology: a bi-centric study (2018) (0)
- Signification du syndrome de Sjögren et des anticorps anti-cN1A chez les patients atteints de myosite (2020) (0)
- OP0057 The patients’ knowledge about their disease: a french multicentric survey in ankylosing spondylitis (as) (2001) (0)
- THU0091 Il-8 production induced by protein i/ii, a modulin from oral streptococci, in synoviocytes from rheumatoid arthritis (ra) patients involves the mapks and fak signalling pathways and nf-kb (2001) (0)
- OP0237 Polymorphisms of Gene Implicated in Type 1 Interferon Pathway Are Associated with The Clinical Response of Rituximab at 24 Weeks in Rheumatoid Arthritis (2016) (0)
- [The therapeutic benefits of systemic treatment of psoriatic arthritis? The example of golimumab in psoriatic arthritis]. (2011) (0)
- Is there a seasonal effect on fatigue, pain and dryness in primary Sjögren's syndrome? Data from the prospective assess cohort and from 3 randomized controlled trials. (2017) (0)
- Reducing the initial number of rituximab maintenance-therapy infusions for ANCA-associated vasculitides: randomized-trial post-hoc analysis. (2020) (0)
- FRI0253 Use of bosentan for the prevention of digital ulcers related to systemic sclerosis. Retrospective french study of 89 patients treated since 2007 (2013) (0)
- Outcome Measures in Sjögren’s Syndrome and Perspectives in Clinical Trial Design (2016) (0)
- Comment prescrire les auto-anticorps: des indications à la « juste prescription » (2016) (0)
- AB0607 Heart Transplantation in 2 Patients with Systemic Sclerosis and Primary Cardiac Involvement (2014) (0)
- SAT0470 Myositis, often suspected, is actually rare in primary sjÖgren’s syndrome: data from the french cohort assess (2018) (0)
- Epilepsie et Paget (1995) (0)
- [Combination therapy for rheumatoid arthritis]. (2002) (0)
- Anticorps anti-pseudo-PCNA : description clinique et biologique d’une cohorte de 96 patients (2014) (0)
- [Hip algodystrophy with bascule in Lobstein's disease]. (1991) (0)
- [Do hematopoietic growth factors have a role in the treatment of drug-induced agranulocytosis?]. (2000) (0)
- MiR-30a-3p represses BAFF secretion by healthy FLS and HDF. (2014) (0)
- Synoviocytes miR-19 in Rheumatoid Fibroblast-like TLR 2 Expression Is Regulated by MicroRNA Wachsmann and (2011) (0)
- Erratum to: Comparison of tocilizumab as monotherapy or with add-on disease-modifying antirheumatic drugs in patients with rheumatoid arthritis and inadequate responses to previous treatments: an open-label study close to clinical practice (2015) (0)
- BONE MINERAL DENSITY IN MEN TREATED WITH SYNTHETIC CARCINOMA GONADOTROPIN-RELEASING HORMONE AGONISTS FOR PROSTATIC (1999) (0)
- [What's new in medicine in 2007?]. (2007) (0)
- Patient acceptable symptom state and minimally clinically important difference for patient-reported outcomes in systemic sclerosis: A secondary analysis of the sclereduc trial (2018) (0)
- POS0947 PSORIATIC ARTHRITIS WITH HYPERURICEMIA: MORE PERIPHERAL, DESTRUCTIVE AND CHALLENGING TO TREAT (2021) (0)
- [Monitoring and precautions to take during treatment with a biological immunomodulator]. (2010) (0)
- THU0362 Aa Amyloidosis Treated by Tocilizumab: Efficacy in Inflammatory And/Or Anti-TNF Alpha Refractory Forms - an International Study (2014) (0)
- [Spondylarthropathy of late onset? RS3PE? An overlap form?]. (1991) (0)
- Systemic Sclerosis : Results from 2 Large European Caucasian Cohorts Autoimmune Risk Loci in CD 58 and ITGAM , ITGAX , Association Study of YANNICK ALLANORE (2011) (0)
- Anticorps anti-pseudo-PCNA de type 1 (anti-SG2NA) : cherchez un cancer, pas le lupus ☆ (2017) (0)
- FRI0247 Serum level of interleukin 33, a novel independent predictive biomarker of clinical response to rituximab in rheumatoid arthritis: results from the smart trial (2013) (0)
- Detection of Shigella spp. nucleic acids in the synovial tissue of Tunisian rheumatoid arthritis patients and other forms of arthritis by quantitative real-time polymerase chain reaction (2018) (0)
- Comparison study between primary Sjogren's syndrome and secondary Sjogren's syndrome Associated with rheumatoid arthritis (2014) (0)
- AB0671 Vitamine D Serum Level Correlates with Quadriceps Muscle Strength in Inflammatory Myositis (2015) (0)
- FRI0167 Anti-TNF do not modify the interferon signature in patients with rheumatoid arthritis and lupus (“rhupus”) (2013) (0)
- THU0364 SYSTEMIC SCLEROSIS OVERLAP AND NON-OVERLAP SYNDROMES SHARE SIMILAR CLINICAL CHARACTERISTICS BUT DRAMATICALLY DIFFERENT TREATMENT. (2020) (0)
- [Inflammatory spondylitis in Verneuil's disease]. (1989) (0)
- THU0412 Reactive hyperemia index (RHI) is associated with macrovascular disease and lung disease in systemic sclerosis (2013) (0)
- AB0410 Diagnosis of lung disease associated with rheumatoid arthritis, a prospective monocentric study (2018) (0)
- Intérêt pronostique du score FIB-4 dans la polyarthrite rhumatoïde : données de la cohorte ESPOIR (2021) (0)
- Une arthrite de cheville d'étiologie inhabituelle (1997) (0)
- Le dosage de la CRP articulaire aide au diagnostic d’arthrite septique sur prothèse (2013) (0)
- Les biothérapies immunomodulatrices: Une révolution thérapeutique dans les maladies auto-immunes (2006) (0)
- Efficacité et tolérance du rituximab dans les atteintes neurologiques centrales du Sjögren primaire : résultats du registre français AIR (2010) (0)
- Comprar Best Practice and Research Clinical Rheumatology | J. Sibilia | 9780702031656 | Elsevier (2008) (0)
- Syndrome de fuite capillaire et maladies systémiques : une association fortuite ? (2015) (0)
- Lymphocytes B ou lymphocytes τ dans les maladies auto-immunes : le lymphocyte τ n'est pas mort ! 2e partie: les lymphocytes τ régulateurs, un nouveau concept (2006) (0)
- Facteurs de risque de mortalité des pneumopathies interstitielles diffuses associées à la polyarthrite rhumatoïde (2022) (0)
- Utilisation du méthotrexate dans la polyarthrite rhumatoïde : établissement de recommandations pour la pratique clinique à partir de données de la littérature et d'opinions d'experts (2005) (0)
- Les maladies auto-immunes : des avancées fondamentales et pratiques : 2ème partie : affections systémiques: actualités pathogéniques, diagnostiques et thérapeutiques (2006) (0)
- Un syndrome de Vogt-Koyanagi-Harada induit par anti TNFα (2006) (0)
- Santé numérique – télémédecine : l’évidence d’une formation universitaire pour tous les professionnels de santé (2022) (0)
- Suivi prospectif du traitement par rituximab chez 410 patients ayant une maladie auto-immune réfractaire: premières données des registres AIR-PR et AIR (2007) (0)
- Une douleur inhabituelle révélatrice d'une maladie de Paget : la fracture de contrainte sous-chondrale juxta-pagétique (2001) (0)
- Une spondylodiscite à Nocardia chez un patient immunocompétent (2007) (0)
- Pneumopathie interstitielle diffuse associée à la polyarthrite rhumatoïde : étude descriptive de 189 patients provenant de la cohorte française TRANSLATE (2016) (0)
- Differenciation des atteintes infectieuses et degeneratives osseuses vertebrales par imagerie cellulaire - resultats cliniques initiaux (2009) (0)
- Recommandations francophones, internationales et multidisciplinaires d’experts pour l’utilisation de biomédicaments dans le lupus érythémateux systémique : le groupe de travail du CRI-IMIDIATE (2016) (0)
- Manifestations rhumatologiques au cours des maladies inflammatoires chroniques intestinales (2018) (0)
- Hépatite E aiguë sous biothérapie (2013) (0)
- Des maladies et des mécanismes auto-immuns inattendus (2007) (0)
- Les corticoïdes : mécanismes d'action (2003) (0)
- Efficacité et tolérance de l'Etanercept au cours de l'arthrite juvénile idiopathique (AJI) (2007) (0)
- Le lupus érythémateux : son histoire et son polymorphisme (2005) (0)
- Fièvre et syndrome inflammatoire inexpliqué chez le sujet âgé, impact thérapeutique de la TEP-TDM au 18F-FDG (2021) (0)
- Efficacité de l’anakinra dans les arthrites induites par les cristaux de pyrophosphate de calcium : étude retrospective de 16 cas (2013) (0)
- Traitement de la polyarthrite rhumatoïde du sujet âgé (COHORTE CORPUS) (2016) (0)
- L'éducation thérapeutique: un concept qui a le vent en poupe (2009) (0)
- Contribution à l'étude des anticorps anti Ro/SS-A et anti La/SS-B : étude clinique et biologique de 50 patients (1991) (0)
- Peut-on prévenir la survenue de douleurs chroniques dans la polyarthrite rhumatoïde? (2022) (0)
- Auto-immunité. 2e Partie syndrôme de Gougerot-Sjögren : Caractéristiques et marqueurs diagnostiques : Dossier auto-immunité (2e partie) (1999) (0)
- Incidence des réactions paradoxales chez les patients traités par tocilizumab pour une polyarthrite rhumatoïde : données du registre français REGATE (2017) (0)
- Intensification thérapeutique et autogreffe de cellules souches hématopoïétiques dans le traitement des maladies auto-immunes résistantes (ISAMAIR) (2001) (0)
- Intensification thérapeutique et autogreffe de cellules souches hématopoïétiques dans le traitement de la sclérodermie réfractaire (2001) (0)
- Des myalgies inhabituelles : une myosite à éosinophiles (2002) (0)
- La fatigue est indépendamment associée à l’activité de la maladie évaluée par le Physician Global Assessment (PGA) chez les patients atteints de lupus systémique (2022) (0)
- Une thrombopénie lupique rebelle au cours d'un syndrome des antiphospgolipides : un casse-tête thérapeutique (2004) (0)
- Analyse comparative des registres de la SFR AIR, ORA et REGATE : un maintien thérapeutique différent en pratique courante (2016) (0)
- 33 – Syndrome catastrophique des antiphospholipides (CAPS) (2013) (0)
- Autogreffe de cellules de cellules souches hématopoïétiques dans la sclérodermie systémique sévère: le protocole européen ASTIS (2006) (0)
- Sclérodermie systémique Seconde partie : prise en charge et perspectives thérapeutiques (2004) (0)
- Y A-T-IL UN RISQUE A PRESCRIRE LE METHOTREXATE DONT L'INDICATION PSORIASIS EST HORS A.M.M. ? (1996) (0)
- Les facteurs de risque des complications digestives et hémorragiques liées à l'aspirine à faibles doses (2003) (0)
- Training on Skin Cancer Diagnosis in Rheumatologists : Results from a Nationwide Randomized Web-Based Survey (2019) (0)
- La borréliose de Lyme : du diagnostic à la thérapeutique (2002) (0)
- Le lupus érythémateux systémique en 2005 (2005) (0)
- Le purpura d’Henoch-Schönlein : une étude comparative de l’enfant et l’adulte. À propos de 135 cas (2012) (0)
- Rôle inhibiteur des TLRs dans la synthèse de BAFF par les synoviocytes fibroblast-like (2006) (0)
- Le gène du facteur d'hypoxie (HIF1A) est associé à la sclérodermie systémique dans une cohorte de patients français caucasiens (2007) (0)
- Identification de marqueurs associés à la présence d’une pneumopathie interstitielle diffuse chez les patients atteints d’une polyarthrite rhumatoïde (2016) (0)
- Nouveaux concepts et nouveaux traitements dans les maladies auto-immunes : les dix points d'actualité (2004) (0)
- Survie à 3 ans de la population ItinérAIR-Sclérodermie (2008) (0)
- Risque de complications systémiques au cours du syndrome de Sjögren primitif et rôle prédictif de la numération sanguine, de l’EPP, du dosage du complément, et de la recherche d’une cryoglobulinémie: données de la cohorte prospective de la SFR ASSESS (2016) (0)
- Données pratiques concernant la prescription des anti-ΤNF (2004) (0)
- Strat??gies d???arr??t ou de r??duction des biom??dicaments dans la polyarthrite rhumato??de en r??mission (2017) (0)
- L'abatacept maintient sur deux ans l'inhibition de la progression radiographique chez des patients insuffisamment répondeurs au méthotrexate (MTX). Résultats à deux ans de l'étude AIM (2006) (0)
- P90 - Fiches anti-TNFδ : un outil pour la pratique quotidienne (2005) (0)
- Efficacité antalgique du pamidronate (PAM) au cours des tassements vertébraux (TV) douloureux nécessitant une hospitalisation : analyse rétrospective de 40 cas (2007) (0)
- Les maladies auto-inflammatoires (2006) (0)
- Lésions osseuses lytiques révélatrices d'acutisation de leucémie myéloïde chroniquea propos de 3 observations sur une série de 235 patients (2001) (0)
- Les complications ostéoarticulaires des déficits immunitaires primitifs (2005) (0)
- Un score prédictif de la survenue de pneumopathie interstitielle diffuse préclinique au cours de la polyarthrite rhumatoïde (2021) (0)
- Organisation des soins : En pratique (2003) (0)
- Lymphocytes B ou lymphocytes T dans les maladies auto-immunes ; le lymphocyte T n'est pas mort ! (2006) (0)
- Un lupus cutané subaigu induit par le léflunomide : efficacité de l'association Interleukine 1-Ra (anakinra) et chloroquine (2006) (0)
- Anti-TNFα: aspects médico-économiques, réglementaires et sociaux (2002) (0)
- TNFα : une cytokine pro-ou antitumorale ? (1) (2007) (0)
- La polyarthrite rhumatoïde : prise en charge médicale à l'heure des biothérapies (2017) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Jean Sibilia?
Jean Sibilia is affiliated with the following schools:
